Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 192.24
Bid: 192.24
Ask: 192.28
Change: 3.06 (1.62%)
Spread: 0.04 (0.021%)
Open: 191.24
High: 193.58
Low: 190.48
Prev. Close: 189.18
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

23 Oct 2020 07:00

RNS Number : 9798C
Barclays PLC
23 October 2020
 

Barclays PLC

Q3 2020 Results Announcement

 

30 September 2020

 

 

Performance Highlights

 

Open for business during the COVID-19 pandemic, helping support the economy

 

COVID-19 support

 

Supporting our customers, clients, communities, and colleagues

·

Provided over 640k payment holidays to customers, c.£25bn of COVID-19 support to UK businesses1 and helped businesses and institutions access global capital markets including underwriting over £1tn of new issuance2 in Q220 and Q320. Also waived c.£100m of interest and fees to customers, and committed to a £100m COVID-19 Community Aid Package

 

Diversified business model delivered a resilient operating performance Q320 YTD

 

Despite the pandemic, Barclays delivered a Q320 YTD Group profit before tax of £2.4bn (Q319 YTD: £3.3bn, included a Payment Protection Insurance (PPI) provision of £1.4bn), a return on tangible equity (RoTE) of 3.6% (Q319 YTD: 5.1%), earnings per share (EPS) of 7.6p (Q319 YTD: 10.4p) and a common equity tier 1 (CET1) ratio of 14.6% (December 2019: 13.8%)

 

Income

 

Diversified income streams with strong Q320 YTD CIB income offsetting challenges in Barclays UK and CC&P

Group income of £16.8bn up 3% versus prior year

·

Barclays International income of £12.4bn, up 11% versus prior year

 

-

Corporate and Investment Bank (CIB) income of £9.8bn, up 24% driven by strong Markets income reflecting wider spreads and market share gains3

 

-

Consumer, Cards and Payments (CC&P) income of £2.6bn, down 21% driven by lower balances, margin compression and reduced payments activity

·

Barclays UK income of £4.7bn down 12% versus prior year reflecting lower interest rates and unsecured lending balances, COVID-19 customer support actions and the removal of certain fees

Credit impairment charges

 

Increased impairment provisioning driving higher coverage ratios across portfolios

Group credit impairment charges increased to £4.3bn (Q319 YTD: £1.4bn) reflecting the impact from revised IFRS 9 scenarios and £0.7bn in respect of single name wholesale loan charges

·

Impairment coverage ratio for the unsecured consumer lending and wholesale portfolios increased to 12.2% (FY19: 8.1%) and 1.5% (FY19: 0.8%) respectively

Costs4

 

Improved cost: income ratio

Group operating expenses of £10.0bn down 1% versus prior year

·

Cost efficiencies and cost discipline contributed to positive cost: income jaws of 4% resulting in an improved cost: income ratio of 59% (Q319 YTD: 62%)

Capital, liquidity and TNAV

 

Strong capital and liquidity position

CET1 ratio of 14.6%, a YTD increase of 80bps

·

The increase over the first nine months of the year reflects profits, regulatory measures and cancellation of the full year 2019 dividend payment, partially offset by a YTD increase in Risk Weighted Assets (RWAs)

·

Headroom of 3.3% above Maximum Distributable Amount (MDA) hurdle of 11.3%5

·

The Group liquidity pool was £327bn (December 2019: £211bn) and the liquidity coverage ratio (LCR) was 181% (December 2019: 160%)

·

Tangible net asset value (TNAV) per share increased to 275p (December 2019: 262p)

 

Q320 performance

 

 

Q320 Barclays UK and CC&P income improved from Q220, whilst CIB remains strong year on year

 

Q320 Group profit before tax of £1.1bn (Q319: £0.2bn), resulting in a RoTE of 5.1% (Q319: (2.4%)) and EPS of 3.5p (Q319: (1.7p))

·

Q320 Group income of £5.2bn, down 6% versus prior year

·

Q320 Barclays International income of £3.8bn, up 1% versus prior year

 

-

Q320 CIB income of £2.9bn, up 11% versus prior year driven by a 29% increase in Markets income, but down 12% versus prior quarter

 

-

Q320 CC&P income of £0.9bn, down 23% versus prior year but up 26% versus prior quarter improved from the Q220 low point reflecting recovery in US cards spend, deposit repricing, UK merchant acquiring volumes, and the non-recurrence of a £100m valuation loss in Barclays' preference shares in Visa Inc.

·

Q320 Barclays UK income of £1.6bn, down 16% versus prior year but up 6% versus prior quarter improved from the Q220 low point with Q320 net interest margin (NIM) stable at 2.51% (Q220: 2.48%)

·

Q320 Group credit impairment charge of £0.6bn, up 32% versus prior year but down 63% versus prior quarter

·

Q320 Group operating expenses of £3.4bn4, up 3% versus prior year and 2% versus prior quarter

·

CET1 ratio of 14.6%, an increase of 40bps in Q320 mainly due to lower RWAs

 

1

Total payment holidays granted as at 30 September 2020, business lending and commercial paper issuance data as at 19 October 2020.

2

Across Equity and Debt Capital Markets.

3

Data source: Coalition, H120 Competitor Analysis. Market share represents Barclays share of the total industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues.

4

Excluding litigation and conduct.

5

Barclays' MDA hurdle will fluctuate depending on the total RWAs at each reporting period and any future regulatory changes.

 

Group outlook

 

Outlook remains uncertain and subject to change depending on the evolution and persistence of the COVID-19 pandemic and the outcome of Brexit negotiations

Income

·

Certain headwinds to income in Barclays UK are expected to persist in 2021 including the low interest rate environment

·

The drivers of CC&P income are showing signs of recovery but the outlook remains uncertain

·

After a strong Q320 YTD CIB performance driven by Markets, the franchise is well positioned for the future

Impairment

·

Provided macroeconomic assumptions remain consistent with expectations, we expect the H220 impairment charge to be materially below that of H120 and it is likely that the full year 2021 impairment charge will be below that of 2020

Costs

·

The Group expects FY20 costs, excluding litigation and conduct, to be broadly flat versus FY19. However, the Group will be evaluating actions to reduce structural costs, which could result in additional charges, the timing and size of which remain to be determined

Capital

·

The Group remains in a strong capital position and is confident of its capital generation capacity over time, acknowledging likely headwinds to the CET1 ratio from procyclical effects on RWAs and reduced benefit from transitional relief on IFRS 9 impairment

·

The Board recognises the importance of capital returns to shareholders and will provide an update on its policy and dividends at FY20 results

 

Barclays Group results

 

for the nine months ended

30.09.20

30.09.19

 

 

£m

£m

% Change

Total income

16,825

16,331

3

Credit impairment charges

(4,346)

(1,389)

 

Net operating income

12,479

14,942

(16)

Operating expenses

(9,954)

(10,051)

1

Litigation and conduct

(106)

(1,682)

94

Total operating expenses

(10,060)

(11,733)

14

Other net income

-

51

 

Profit before tax

2,419

3,260

(26)

Tax charge

(441)

(814)

46

Profit after tax

1,978

2,446

(19)

Non-controlling interests

(41)

(38)

(8)

Other equity instrument holders

(631)

(628)

-

Attributable profit

1,306

1,780

(27)

 

 

 

 

Performance measures

 

 

 

Return on average tangible shareholders' equity

3.6%

5.1%

 

Average tangible shareholders' equity (£bn)

 48.5

 46.6

 

Cost: income ratio

60%

72%

 

Loan loss rate (bps)

164

53

 

Basic earnings per share

7.6p

10.4p

 

Dividend per share

-

3.0p

 

 

 

 

Performance measures excluding litigation and conduct1

 

 

 

Profit before tax

2,525

4,942

(49)

Attributable profit

1,378

3,391

(59)

Return on average tangible shareholders' equity

3.8%

9.7%

 

Cost: income ratio

59%

62%

 

Basic earnings per share

8.0p

19.7p

 

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet and capital management2

£bn

£bn

£bn

Loans and advances at amortised cost

344.4

339.1

345.1

Deposits at amortised cost

494.6

415.8

420.6

Tangible net asset value per share

275p

262p

274p

Common equity tier 1 ratio

14.6%

13.8%

13.4%

Common equity tier 1 capital

45.5

40.8

41.9

Risk weighted assets

310.7

295.1

313.3

Average UK leverage ratio

5.1%

4.5%

4.6%

UK leverage ratio

5.2%

5.1%

4.8%

 

 

 

 

Funding and liquidity

 

 

 

Group liquidity pool (£bn)

327

211

226

Liquidity coverage ratio

181%

160%

151%

Loan: deposit ratio

70%

82%

82%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

2

Refer to pages 29 to 35 for further information on how capital, RWAs and leverage are calculated.

 

Group Chief Executive Officer's Review

 

"In this historically challenging year for our customers and clients we have continued to provide huge support to help people through the social and economic impact of the COVID-19 pandemic. This remains a priority, alongside maintaining the financial integrity of the firm and keeping our colleagues safe.

 

For customers, we have provided over 640,000 payment holidays globally1, and this is in addition to some £100m of income foregone in the form of waived overdraft interest and banking charges for our UK customers and business banking clients.

 

We have now delivered some £25bn through the government support measures to UK businesses.1 This includes 296,000 Bounce Back Loans totalling £9.2bn, around £3bn under the CBILS programmes2, and £12.4bn through the Covid Corporate Financing Facility.1 In addition, we have helped businesses and institutions to access global capital markets, including underwriting over £1tn of new issuance in Q220 and Q320.3

 

Our £100m Community Aid Package is making a positive difference for thousands of people via hundreds of charities we have supported which are mitigating the impact of COVID-19, including donations to NHS hospital charities, Age UK and Mind.

 

This support is made partly possible because we have a resilient and diversified business model which means we remain profitable as we weather this crisis, with strong income performance in our CIB more than offsetting headwinds in our consumer businesses.

 

In the first nine months Group income increased 3% to £16.8bn with pre-provision profits4 increasing 9% to £6.9bn.

 

Our impairment charges now total £4.3bn, with an additional £608m taken in Q320, a figure down 63% on the previous quarter. We expect the impairment charge in the second half of the year to be materially lower than the first half.

 

Group profit before tax for the first nine months was £2.4bn, with the Group remaining profitable in each quarter so far.

 

In Barclays International, CIB income increased 24% to £9.8bn with Markets income up 52% mainly reflecting wider spreads and market share gains.5 Profit before tax in the CIB increased 25% to £3.2bn.

 

Our CC&P business returned to profitability in the third quarter with profit before tax of £165m, reducing the year to date loss before tax to £449m, which included impairment charges of £1.5bn.

 

Barclays UK also returned to profitability in the third quarter, with profit before tax of £196m, as economic activity recovered from the spring low point and impairment charges reduced. For the first nine months Barclays UK delivered profit before tax of £264m. Income headwinds in Barclays UK are expected to persist into 2021 including the low interest rate environment.

 

Group costs excluding litigation and conduct are down 1% at £10.0bn, resulting in positive cost to income jaws of 4%, and an improved cost to income ratio of 59%.

 

Group RoTE was 3.6% including 10.5% for the CIB; and 2.2% for Barclays UK. The Group generated EPS of 7.6 pence.

 

In the third quarter Group income was £5.2bn and Group profit before tax increased to £1.1bn due to the non-recurrence of the 2019 PPI provision.

 

Our CET1 ratio increased 40bps in the quarter to 14.6%, more than 300 basis points above our regulatory minimum. The Board recognises the importance of capital returns to shareholders and will provide an update on its policy and dividends at full year results."

 

James E Staley, Group Chief Executive Officer

 

1

Total payment holidays granted as at 30 September 2020, business lending and commercial paper issuance data as at 19 October 2020.

2

The Coronavirus Business Interruption Loan Scheme (CBILS) and the Coronavirus Large Business Interruption Loan Scheme programmes (together the CBILS programmes).

3

Across Equity and Debt Capital Markets.

4

Excluding litigation and conduct.

5

Data source: Coalition, H120 Competitor Analysis Market share represents Barclays share of the total industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues.

 

Group Finance Director's Review

 

Group performance

 

·

Statutory RoTE was 3.6% (Q319 YTD: 5.1%) and statutory EPS was 7.6p (Q319 YTD: 10.4p)

·

Profit before tax was £2,419m (Q319 YTD: £3,260m). Excluding litigation and conduct, profit before tax was £2,525m (Q319 YTD: £4,942m), as positive operating leverage from a 3% increase in income and 1% reduction in operating expenses was offset by materially higher credit impairment charges

·

Pre-provision profits1 increased 9% to £6,871m, benefitting from the Group's diversified business model, as strong performance in CIB more than offset income headwinds in Barclays UK and CC&P

·

Total income increased 3% to £16,825m. Barclays UK income decreased 12%. Barclays International income increased 11%, with CIB income up 24% and CC&P income down 21%

·

Credit impairment charges increased to £4,346m (Q319 YTD: £1,389m). This increase was primarily driven by the impact from revised IFRS 9 scenarios (the "COVID-19 scenarios") reflecting forecast deterioration in macroeconomic variables (including a prolonged period of heightened UK and US unemployment), partially offset by the estimated impact of central bank, government and other support measures, and £746m in respect of single name wholesale loan charges in CIB

·

Operating expenses decreased 1% to £9,954m reflecting cost efficiencies and continued cost discipline in the current environment. The Group delivered positive cost: income jaws of 4% which resulted in the Group cost: income ratio, excluding litigation and conduct, reducing to 59% (Q319 YTD: 62%)

·

The effective tax rate was 18.2% (Q319 YTD: 25.0%). This reflects the tax benefit recognised for a re-measurement of UK deferred tax assets as a result of the UK corporation tax rate being maintained at 19%. The Group's effective tax rate for the full year is expected to be around 20%, excluding litigation and conduct

·

Attributable profit was £1,306m (Q319 YTD: £1,780m). Excluding litigation and conduct, attributable profit was £1,378m (Q319 YTD: £3,391m), generating a RoTE of 3.8% (Q319 YTD: 9.7%) and EPS of 8.0p (Q319 YTD: 19.7p)

·

Total assets increased to £1,422bn (December 2019: £1,140bn), primarily due to a £91bn increase in cash and balances at central banks, £67bn increase in derivative assets and £50bn increase in financial assets at fair value through the income statement. This is due to the low interest rate environment, increased client activity and the appreciation of period end USD against GBP

·

Loans and advances at amortised cost increased by £5bn to £344bn, which reflects the £9.7bn of lending under the government backed Bounce Back Loan Scheme (BBLS) and the CBILS which Barclays UK has provided to support businesses through the COVID-19 pandemic and £3.2bn of mortgage growth. This was partially offset by lower card balances

·

Deposits at amortised cost increased by £79bn to £495bn, primarily due to CIB clients increasing liquidity, lower consumer spending levels and precautionary balance build

·

TNAV per share increased to 275p (December 2019: 262p) reflecting 7.6p of statutory EPS and positive reserve movements, including retirement benefit re-measurements and currency translation reserves

 

Barclays UK

 

·

Profit before tax, excluding litigation and conduct, was £300m (Q319 YTD: £1,899m). RoTE was 2.5% (Q319 YTD: 17.2%) reflecting a challenging operating environment and materially higher credit impairment charges

·

Total income decreased 12% to £4,721m. Net interest income reduced 11% to £3,917m with a NIM of 2.63% (Q319 YTD: 3.10%). Net fee, commission and other income decreased 18% to £804m

 

-

Personal Banking income decreased 11% to £2,627m, reflecting deposit margin compression, COVID-19 customer support actions, and lower unsecured lending balances, partially offset by deposit balance growth and transfer of Barclays Partner Finance (BPF) from Barclays International in Q220

 

-

Barclaycard Consumer UK income decreased 20% to £1,165m as reduced borrowing and spend levels by customers resulted in a lower level of interest earning lending (IEL) balances, as well as planned lower debt sales

 

-

Business Banking income decreased 6% to £929m due to deposit margin compression, lower transactional fee volumes as a result of COVID-19 and related customer support actions, partially offset by balance growth

·

Credit impairment charges increased to £1,297m (Q319 YTD: £522m) reflecting forecast deterioration in macroeconomic variables in the COVID-19 scenarios, partially offset by the estimated impact of central bank, government and other support measures. As at 30 September 2020, 30 and 90 day arrears rates in UK cards were 1.7% (Q319: 1.7%) and 0.8% (Q319: 0.8%) respectively

·

Operating expenses increased 5% to £3,136m as efficiency savings were more than offset by higher servicing and financial assistance costs, as well as the transfer of BPF and further investment

·

Loans and advances to customers at amortised cost increased 5% to £203.9bn predominantly through £9.7bn of BBLS and CBILS lending, £3.2bn of mortgage growth and the £2.2bn transfer of BPF, partially offset by £4.0bn lower UK cards balances

·

Customer deposits at amortised cost increased 13% to £232.0bn due to lower customer spending and precautionary balance build

·

RWAs increased to £76.2bn (December 2019: £74.9bn) driven by the transfer of BPF and growth in mortgages, partially offset by a reduction in consumer loans

 

1

Excluding litigation and conduct.

 

Barclays International

 

·

Profit before tax, excluding litigation and conduct, decreased 19% to £2,833m with a RoTE of 7.6% (Q319 YTD: 10.4%), reflecting a RoTE of 10.5% (Q319 YTD: 9.3%) in CIB and (9.9)% (Q319 YTD: 15.8%) in CC&P

·

Total income increased to £12,435m (Q319 YTD: £11,223m)

 

-

CIB income increased 24% to £9,838m

 

 

-

Markets income of £6,255m (Q319 YTD: £4,116m) was the best ever Q3 YTD on a comparable basis1 reflecting an increase in market share in the first half of the year2. FICC income increased 64% to £4,326m driven by strong performances in macro and credit, mainly reflecting wider spreads. Equities income increased 31% to £1,929m driven by derivatives and cash due to higher levels of client activity and volatility

 

 

-

Banking fees income increased 1% to £1,977m as a strong performance in equity and debt capital markets, representing the best ever Q3 YTD on a comparable basis for these businesses1, was offset by lower fee income in advisory which was impacted by a reduced fee pool3

 

 

-

Within Corporate, Transaction banking income decreased 6% to £1,202m as deposit balance growth was more than offset by margin compression. Corporate lending income decreased by 28% to £404m reflecting c.£210m of losses on fair value lending positions and on mark-to-market and carry costs on related hedges in Q320 YTD

 

-

CC&P income decreased 21% to £2,597m as the impacts of the COVID-19 pandemic resulted in lower balances on co-branded cards, margin compression and reduced payments activity. Q220 included a c.£100m valuation loss on Barclays' preference shares in Visa Inc. resulting from the Q220 Supreme Court ruling concerning charges paid by merchants

·

Credit impairment charges increased to £2,989m (Q319 YTD: £844m)

 

-

CIB credit impairment charges increased to £1,507m (Q319 YTD: £127m), reflecting £746m in respect of single name wholesale loan charges and the impact from updates to forecast macroeconomic variables, partially offset by the estimated impact of central bank, government and other support measures

 

-

CC&P credit impairment charges increased to £1,482m (Q319 YTD: £717m) reflecting the impact from updates to forecast macroeconomic variables, partially offset by the estimated impact of central bank, government and other support measures. As at 30 September 2020, 30 and 90 day arrears in US cards were 2.3% (Q319: 2.6%) and 1.1% (Q319: 1.3%) respectively

·

Operating expenses decreased 4% to £6,632m

 

-

CIB operating expenses decreased 2% to £5,086m due to cost efficiencies and discipline in the current environment

 

-

CC&P operating expenses decreased 11% to £1,546m reflecting cost efficiencies, lower marketing spend due to the impacts of the COVID-19 pandemic and transfer of BPF to Barclays UK in Q220

·

RWAs increased to £224.7bn (December 2019: £209.2bn) primarily due to increased market volatility, client activity and a reduction in credit quality within CIB, partially offset by lower CC&P balances

 

1

Period covering Q114 - Q320. Pre 2014 financials were not restated following re-segmentation in Q116.

2

Data source: Coalition, H120 Competitor Analysis. Market share represents Barclays share of the total industry Revenue Pool. Analysis is based on Barclays internal business structure and internal revenues.

3

Data source: Dealogic for the period covering 1 January to 30 September 2020.

 

Head Office

 

·

Loss before tax, excluding litigation and conduct, was £608m (Q319 YTD: £465m)

·

Total income was an expense of £331m (Q319 YTD: £286m), which included treasury items and hedge accounting, mark-to-market losses on legacy investments and funding costs of legacy capital instruments, partially offset by the recognition of dividends on Barclays' stake in Absa Group Limited

·

Credit impairment charges increased to £60m (Q319 YTD: £23m) due to impacts from the COVID-19 scenarios on the Italian home loan portfolio, partially offset by the estimated impact of central bank, government and other support measures

·

Operating expenses were £186m (Q319 YTD: £155m), which included £73m of charitable donations from Barclays' COVID-19 Community Aid Package

·

Other net expenses were £31m (Q319 YTD: £1m), which included a fair value loss on an investment in an associate

·

RWAs decreased to £9.8bn (December 2019: £11.0bn) driven by the reduction in value of Barclays' stake in Absa Group Limited

 

Group capital and leverage

 

·

The CET1 ratio increased to 14.6% (December 2019: 13.8%)

 

-

CET1 capital increased by £4.7bn to £45.5bn reflecting resilient capital generation through £6.3bn of profits after tax, excluding credit impairment charges and a £1.0bn increase due to the cancellation of the full year 2019 dividend. The CET1 capital increase also reflects new regulatory measures implemented in June 2020 for IFRS 9 transitional relief and prudent valuation

 

-

RWAs increased by £15.6bn to £310.7bn primarily due to higher market volatility and client activity within CIB as well as a reduction in credit quality, partially offset by lower consumer lending

·

The average UK leverage ratio increased to 5.1% (December 2019: 4.5%) primarily driven by the increase in CET1 capital. The average leverage exposure decreased by £32bn to £1,111bn (December 2019: £1,143bn) largely driven by the Prudential Regulation Authority's (PRA) early adoption of CRR II settlement netting

 

Group funding and liquidity

 

·

The liquidity pool was £327bn (December 2019: £211bn) and the LCR remained significantly above the 100% regulatory requirement at 181% (December 2019: 160%), equivalent to a surplus of £143bn (December 2019: £78bn). The increase in the liquidity pool, LCR and surplus is driven by a 19% growth in customer deposits and actions to maintain a prudent funding and liquidity position in the current environment

·

Wholesale funding outstanding, excluding repurchase agreements, was £175.3bn (December 2019: £147.1bn). The Group issued £6.6bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) during the year to date. The Group is well advanced in its MREL issuance plans, with a Barclays PLC MREL ratio of 32.8% as at 30 September 2020 (December 2019: 31.2%) relative to an estimated requirement (including requisite buffers) of c.29.9% by 1 January 2022

 

Other matters

 

·

As at 30 September 2020, the Group held a provision of £300m relating to PPI. Since the provision increase to £1.4bn in Q319, 96% of the items outstanding as at 30 September 2019 have been resolved (including invalid items and claims from the Official Receiver with whom we reached an agreement in Q320). Observations from these resolved complaints continue to support the provision level

 

Group outlook and targets

 

Outlook remains uncertain and subject to change depending on the evolution and persistence of the COVID-19 pandemic and the outcome of Brexit negotiations

 

Income

·

Certain headwinds to income in Barclays UK are expected to persist in 2021 including the low interest rate environment

·

The drivers of CC&P income are showing signs of recovery but the outlook remains uncertain

·

After a strong Q320 YTD CIB performance driven by Markets, the franchise is well positioned for the future

Impairment

·

Provided macroeconomic assumptions remain consistent with expectations, we expect the H220 impairment charge to be materially below that of H120 and it is likely that the full year 2021 impairment charge will be below that of 2020

Costs

·

The Group expects FY20 costs, excluding litigation and conduct, to be broadly flat versus FY19. However, the Group will be evaluating actions to reduce structural costs, which could result in additional charges, the timing and size of which remain to be determined

Capital

·

The Group remains in a strong capital position and is confident of its capital generation capacity over time, acknowledging likely headwinds to the CET1 ratio from procyclical effects on RWAs and reduced benefit from transitional relief on IFRS 9 impairment

·

The Board recognises the importance of capital returns to shareholders and will provide an update on its policy and dividends at FY20 results

Targets

·

The Group continues to target a RoTE of >10%1 and cost: income ratio of

 

Tushar Morzaria, Group Finance Director

 

1

Excluding litigation and conduct.

 

Results by Business

 

Barclays UK

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Income statement information

£m

£m

% Change

Net interest income

3,917

4,410

(11)

Net fee, commission and other income

804

984

(18)

Total income

4,721

5,394

(12)

Credit impairment charges

(1,297)

(522)

 

Net operating income

3,424

4,872

(30)

Operating expenses

(3,136)

(2,973)

(5)

Litigation and conduct

(36)

(1,524)

98

Total operating expenses

(3,172)

(4,497)

29

Other net income

12

-

 

Profit before tax

264

375

(30)

Attributable profit/(loss)

165

(157)

 

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet information

£bn

£bn

£bn

Loans and advances to customers at amortised cost

203.9

193.7

193.2

Total assets

294.5

257.8

257.9

Customer deposits at amortised cost

232.0

205.5

203.3

Loan: deposit ratio

91%

96%

97%

Risk weighted assets

76.2

74.9

76.8

Period end allocated tangible equity

10.0

10.3

10.4

 

 

 

 

 

Nine months ended

Nine months ended

 

Performance measures

30.09.20

30.09.19

 

Return on average allocated tangible equity

2.2%

(2.0%)

 

Average allocated tangible equity (£bn)

10.2

10.4

 

Cost: income ratio

67%

83%

 

Loan loss rate (bps)

81

35

 

Net interest margin

2.63%

3.10%

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

% Change

Profit before tax

300

1,899

(84)

Attributable profit

190

1,332

(86)

Return on average allocated tangible equity

2.5%

17.2%

 

Cost: income ratio

66%

55%

 

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Analysis of Barclays UK

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Analysis of total income

£m

£m

% Change

Personal Banking

2,627

2,945

(11)

Barclaycard Consumer UK

1,165

1,459

(20)

Business Banking

929

990

(6)

Total income

4,721

5,394

(12)

 

 

 

 

Analysis of credit impairment charges

 

 

 

Personal Banking

(312)

(124)

 

Barclaycard Consumer UK

(803)

(364)

 

Business Banking

(182)

(34)

 

Total credit impairment charges

(1,297)

(522)

 

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

Personal Banking

155.7

151.9

150.1

Barclaycard Consumer UK

10.7

14.7

14.9

Business Banking

37.5

27.1

28.2

Total loans and advances to customers at amortised cost

203.9

193.7

193.2

 

 

 

 

Analysis of customer deposits at amortised cost

 

 

 

Personal Banking

173.2

159.2

157.9

Barclaycard Consumer UK

0.1

-

-

Business Banking

58.7

46.3

45.4

Total customer deposits at amortised cost

232.0

205.5

203.3

 

Barclays International

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Income statement information

£m

£m

% Change

Net interest income

2,668

2,976

(10)

Net trading income

5,548

3,270

70

Net fee, commission and other income

4,219

4,977

(15)

Total income

12,435

11,223

11

Credit impairment charges

(2,989)

(844)

 

Net operating income

9,446

10,379

(9)

Operating expenses

(6,632)

(6,923)

4

Litigation and conduct

(39)

(30)

(30)

Total operating expenses

(6,671)

(6,953)

4

Other net income

19

52

(63)

Profit before tax

2,794

3,478

(20)

Attributable profit

1,779

2,419

(26)

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet information

£bn

£bn

£bn

Loans and advances at amortised cost

128.0

132.8

138.1

Trading portfolio assets

122.3

113.3

119.4

Derivative financial instrument assets

295.9

228.9

286.0

Financial assets at fair value through the income statement

178.2

128.4

158.0

Cash collateral and settlement balances

121.8

79.4

112.5

Other assets

261.7

178.6

195.6

Total assets

1,107.9

861.4

1,009.6

Deposits at amortised cost

262.4

210.0

217.6

Derivative financial instrument liabilities

293.3

228.9

283.3

Loan: deposit ratio

49%

63%

63%

Risk weighted assets

224.7

209.2

223.1

Period end allocated tangible equity

30.5

29.6

31.4

 

 

 

 

 

Nine months ended

Nine months ended

 

Performance measures

30.09.20

30.09.19

 

Return on average allocated tangible equity

7.5%

10.3%

 

Average allocated tangible equity (£bn)

31.8

31.2

 

Cost: income ratio

54%

62%

 

Loan loss rate (bps)

300

80

 

Net interest margin

3.71%

4.00%

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

% Change

Profit before tax

2,833

3,508

(19)

Attributable profit

1,808

2,445

(26)

Return on average allocated tangible equity

7.6%

10.4%

 

Cost: income ratio

53%

62%

 

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Analysis of Barclays International

 

 

 

Corporate and Investment Bank

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Income statement information

£m

£m

% Change

FICC

4,326

2,638

64

Equities

1,929

1,478

31

Markets

6,255

4,116

52

Advisory

329

574

(43)

Equity capital markets

369

273

35

Debt capital markets

1,279

1,108

15

Banking fees

1,977

1,955

1

Corporate lending

404

563

(28)

Transaction banking

1,202

1,283

(6)

Corporate

1,606

1,846

(13)

Total income

9,838

7,917

24

Credit impairment charges

(1,507)

(127)

 

Net operating income

8,331

7,790

7

Operating expenses

(5,086)

(5,191)

2

Litigation and conduct

(6)

(30)

80

Total operating expenses

(5,092)

(5,221)

2

Other net income

4

27

(85)

Profit before tax

3,243

2,596

25

Attributable profit

2,141

1,787

20

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet information

£bn

£bn

£bn

Loans and advances at amortised cost

96.8

92.0

95.8

Trading portfolio assets

122.2

113.3

119.3

Derivative financial instrument assets

295.9

228.8

286.0

Financial assets at fair value through the income statement

177.9

127.7

157.3

Cash collateral and settlement balances

121.0

78.5

111.6

Other assets

228.9

155.3

171.5

Total assets

1,042.7

795.6

941.5

Deposits at amortised cost

195.6

146.2

152.1

Derivative financial instrument liabilities

293.2

228.9

283.2

Risk weighted assets

193.3

171.5

184.9

 

 

 

 

 

Nine months ended

Nine months ended

 

Performance measures

30.09.20

30.09.19

 

Return on average allocated tangible equity

10.5%

9.2%

 

Average allocated tangible equity (£bn)

27.2

25.9

 

Cost: income ratio

52%

66%

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

% Change

Profit before tax

3,249

2,626

24

Attributable profit

2,145

1,813

18

Return on average allocated tangible equity

10.5%

9.3%

 

Cost: income ratio

52%

66%

 

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Analysis of Barclays International

 

 

 

Consumer, Cards and Payments

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Income statement information

£m

£m

% Change

Net interest income

1,694

2,105

(20)

Net fee, commission, trading and other income

903

1,201

(25)

Total income

2,597

3,306

(21)

Credit impairment charges

(1,482)

(717)

 

Net operating income

1,115

2,589

(57)

Operating expenses

(1,546)

(1,732)

11

Litigation and conduct

(33)

-

 

Total operating expenses

(1,579)

(1,732)

9

Other net income

15

25

(40)

(Loss)/profit before tax

(449)

882

 

Attributable (loss)/profit

(362)

632

 

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet information

£bn

£bn

£bn

Loans and advances at amortised cost

31.2

40.8

42.3

Total assets

65.2

65.8

68.1

Deposits at amortised cost

66.8

63.8

65.5

Risk weighted assets

31.4

37.7

38.2

 

 

 

 

 

Nine months ended

Nine months ended

 

Performance measures

30.09.20

30.09.19

 

Return on average allocated tangible equity

(10.6%)

15.8%

 

Average allocated tangible equity (£bn)

4.6

5.3

 

Cost: income ratio

61%

52%

 

Loan loss rate (bps)

577

213

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

% Change

(Loss)/profit before tax

(416)

882

 

Attributable (loss)/profit

(337)

632

 

Return on average allocated tangible equity

(9.9%)

15.8%

 

Cost: income ratio

60%

52%

 

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Head Office

Nine months ended

Nine months ended

 

30.09.20

30.09.19

 

Income statement information

£m

£m

% Change

Net interest income

(307)

(323)

5

Net fee, commission and other income

(24)

37

 

Total income

(331)

(286)

(16)

Credit impairment charges

(60)

(23)

 

Net operating income

(391)

(309)

(27)

Operating expenses

(186)

(155)

(20)

Litigation and conduct

(31)

(128)

76

Total operating expenses

(217)

(283)

23

Other net expenses

(31)

(1)

 

Loss before tax

(639)

(593)

(8)

Attributable loss

(638)

(482)

(32)

 

 

 

 

 

As at 30.09.20

As at 31.12.19

As at 30.09.19

Balance sheet information

£bn

£bn

£bn

Total assets

19.3

21.0

22.9

Risk weighted assets

9.8

11.0

13.4

Period end allocated tangible equity

7.1

5.6

5.5

 

 

 

 

 

Nine months ended

Nine months ended

 

Performance measures

30.09.20

30.09.19

 

Average allocated tangible equity (£bn)

6.5

5.0

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

% Change

Loss before tax

(608)

(465)

(31)

Attributable loss

(620)

(386)

(61)

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Quarterly Results Summary

 

Barclays Group

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Net interest income

2,055

1,892

2,331

 

2,344

2,445

2,360

2,258

 

2,296

Net fee, commission and other income

3,149

3,446

3,952

 

2,957

3,096

3,178

2,994

 

2,777

Total income

5,204

5,338

6,283

 

5,301

5,541

5,538

5,252

 

5,073

Credit impairment charges

(608)

(1,623)

(2,115)

 

(523)

(461)

(480)

(448)

 

(643)

Net operating income

4,596

3,715

4,168

 

4,778

5,080

5,058

4,804

 

4,430

Operating costs

(3,391)

(3,310)

(3,253)

 

(3,308)

(3,293)

(3,501)

(3,257)

 

(3,624)

UK bank levy

-

-

-

 

(226)

-

-

-

 

(269)

Operating expenses

(3,391)

(3,310)

(3,253)

 

(3,534)

(3,293)

(3,501)

(3,257)

 

(3,893)

Guaranteed Minimum Pensions (GMP) charge

-

-

-

 

-

-

-

-

 

(140)

Litigation and conduct

(76)

(20)

(10)

 

(167)

(1,568)

(53)

(61)

 

(60)

Total operating expenses

(3,467)

(3,330)

(3,263)

 

(3,701)

(4,861)

(3,554)

(3,318)

 

(4,093)

Other net income/(expenses)

18

(26)

8

 

20

27

27

(3)

 

37

Profit before tax

1,147

359

913

 

1,097

246

1,531

1,483

 

374

Tax charge

(328)

(42)

(71)

 

(189)

(269)

(297)

(248)

 

(75)

Profit/(loss) after tax

819

317

842

 

908

(23)

1,234

1,235

 

299

Non-controlling interests

(4)

(21)

(16)

 

(42)

(4)

(17)

(17)

 

(83)

Other equity instrument holders

(204)

(206)

(221)

 

(185)

(265)

(183)

(180)

 

(230)

Attributable profit/(loss)

611

90

605

 

681

(292)

1,034

1,038

 

(14)

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Return on average tangible shareholders' equity

5.1%

0.7%

5.1%

 

5.9%

(2.4%)

9.0%

9.2%

 

(0.1%)

Average tangible shareholders' equity (£bn)

48.3

50.2

47.0

 

46.4

48.4

46.2

45.2

 

44.3

Cost: income ratio

67%

62%

52%

 

70%

88%

64%

63%

 

81%

Loan loss rate (bps)

69

179

223

 

60

52

56

54

 

77

Basic earnings/(loss) per share

3.5p

0.5p

3.5p

 

3.9p

(1.7p)

6.0p

6.1p

 

(0.1p)

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit before tax

1,223

379

923

 

1,264

1,814

1,584

1,544

 

434

Attributable profit

668

106

604

 

803

1,233

1,074

1,084

 

48

Return on average tangible shareholders' equity

5.5%

0.8%

5.1%

 

6.9%

10.2%

9.3%

9.6%

 

0.4%

Cost: income ratio

65%

62%

52%

 

67%

59%

63%

62%

 

79%

Basic earnings per share

3.9p

0.6p

3.5p

 

4.7p

7.2p

6.3p

6.3p

 

0.3p

 

 

 

 

 

 

 

 

 

 

 

Balance sheet and capital management2

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Loans and advances at amortised cost

344.4

354.9

374.1

 

339.1

345.1

339.3

330.7

 

326.4

Total assets

1,421.7

1,385.1

1,444.3

 

1,140.2

1,290.4

1,232.8

1,193.5

 

1,133.3

Deposits at amortised cost

494.6

466.9

470.7

 

415.8

420.6

413.6

412.7

 

394.8

Tangible net asset value per share

275p

284p

284p

 

262p

274p

275p

266p

 

262p

Common equity tier 1 ratio

14.6%

14.2%

13.1%

 

13.8%

13.4%

13.4%

13.0%

 

13.2%

Common equity tier 1 capital

45.5

45.4

42.5

 

40.8

41.9

42.9

41.4

 

41.1

Risk weighted assets

310.7

319.0

325.6

 

295.1

313.3

319.1

319.7

 

311.9

Average UK leverage ratio

5.1%

4.7%

4.5%

 

4.5%

4.6%

4.7%

4.6%

 

4.5%

Average UK leverage exposure

1,111.1

1,148.7

1,176.2

 

1,142.8

1,171.2

1,134.6

1,105.5

 

1,110.0

UK leverage ratio

5.2%

5.2%

4.5%

 

5.1%

4.8%

5.1%

4.9%

 

5.1%

UK leverage exposure

1,095.1

1,071.1

1,178.7

 

1,007.7

1,099.8

1,079.4

1,065.0

 

998.6

 

 

 

 

 

 

 

 

 

 

 

Funding and liquidity

 

 

 

 

 

 

 

 

 

 

Group liquidity (£bn)

327

298

237

 

211

226

238

232

 

227

Liquidity coverage ratio

181%

186%

155%

 

160%

151%

156%

160%

 

169%

Loan: deposit ratio

70%

76%

79%

 

82%

82%

82%

80%

 

83%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

2

Refer to pages 29 to 35 for further information on how capital, RWAs and leverage are calculated.

 

Quarterly Results by Business

 

Barclays UK

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Net interest income

1,280

1,225

1,412

 

1,478

1,503

1,438

1,469

 

1,513

Net fee, commission and other income

270

242

292

 

481

343

333

308

 

350

Total income

1,550

1,467

1,704

 

1,959

1,846

1,771

1,777

 

1,863

Credit impairment charges

(233)

(583)

(481)

 

(190)

(101)

(230)

(191)

 

(296)

Net operating income

1,317

884

1,223

 

1,769

1,745

1,541

1,586

 

1,567

Operating costs

(1,095)

(1,018)

(1,023)

 

(1,023)

(952)

(1,022)

(999)

 

(1,114)

UK bank levy

-

-

-

 

(41)

-

-

-

 

(46)

Operating expenses

(1,095)

(1,018)

(1,023)

 

(1,064)

(952)

(1,022)

(999)

 

(1,160)

Litigation and conduct

(25)

(6)

(5)

 

(58)

(1,480)

(41)

(3)

 

(15)

Total operating expenses

(1,120)

(1,024)

(1,028)

 

(1,122)

(2,432)

(1,063)

(1,002)

 

(1,175)

Other net (expenses)/income

(1)

13

-

 

-

-

(1)

1

 

(2)

Profit/(loss) before tax

196

(127)

195

 

647

(687)

477

585

 

390

Attributable profit/loss

113

(123)

175

 

438

(907)

328

422

 

241

 

 

 

 

 

 

 

 

 

 

 

Balance sheet information

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Loans and advances to customers at amortised cost

203.9

202.0

195.7

 

193.7

193.2

189.1

187.5

 

187.6

Total assets

294.5

287.6

267.5

 

257.8

257.9

259.0

253.1

 

249.7

Customer deposits at amortised cost

232.0

225.7

207.5

 

205.5

203.3

200.9

197.3

 

197.3

Loan: deposit ratio

91%

92%

96%

 

96%

97%

97%

96%

 

96%

Risk weighted assets

76.2

77.9

77.7

 

74.9

76.8

76.2

76.6

 

75.2

Period end allocated tangible equity

10.0

10.3

10.3

 

10.3

10.4

10.3

10.5

 

10.2

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

4.5%

(4.8%)

6.9%

 

17.0%

(34.9%)

12.7%

16.3%

 

9.6%

Average allocated tangible equity (£bn)

10.1

10.3

10.1

 

10.3

10.4

10.3

10.4

 

10.1

Cost: income ratio

72%

70%

60%

 

57%

132%

60%

56%

 

63%

Loan loss rate (bps)

43

111

96

 

38

20

47

40

 

61

Net interest margin

2.51%

2.48%

2.91%

 

3.03%

3.10%

3.05%

3.18%

 

3.20%

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit/(loss) before tax

221

(121)

200

 

705

793

518

588

 

405

Attributable profit/(loss)

130

(118)

178

 

481

550

358

424

 

253

Return on average allocated tangible equity

5.2%

(4.6%)

7.0%

 

18.7%

21.2%

13.9%

16.4%

 

10.1%

Cost: income ratio

71%

69%

60%

 

54%

52%

58%

56%

 

62%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Analysis of Barclays UK

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Analysis of total income

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Personal Banking

833

826

968

 

1,064

1,035

946

964

 

998

Barclaycard Consumer UK

362

367

436

 

533

472

497

490

 

522

Business Banking

355

274

300

 

362

339

328

323

 

343

Total income

1,550

1,467

1,704

 

1,959

1,846

1,771

1,777

 

1,863

 

 

 

 

 

 

 

 

 

 

 

Analysis of credit impairment (charges)/releases

 

 

 

 

 

 

 

 

 

 

Personal Banking

(48)

(130)

(134)

 

(71)

(36)

(36)

(52)

 

(44)

Barclaycard Consumer UK

(106)

(396)

(301)

 

(108)

(49)

(175)

(140)

 

(250)

Business Banking

(79)

(57)

(46)

 

(11)

(16)

(19)

1

 

(2)

Total credit impairment charges

(233)

(583)

(481)

 

(190)

(101)

(230)

(191)

 

(296)

 

 

 

 

 

 

 

 

 

 

 

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Personal Banking

155.7

154.9

153.4

 

151.9

150.1

147.3

145.9

 

146.0

Barclaycard Consumer UK

10.7

11.5

13.6

 

14.7

14.9

15.1

15.0

 

15.3

Business Banking

37.5

35.6

28.7

 

27.1

28.2

26.7

26.6

 

26.3

Total loans and advances to customers at amortised cost

203.9

202.0

195.7

 

193.7

193.2

189.1

187.5

 

187.6

 

 

 

 

 

 

 

 

 

 

 

Analysis of customer deposits at amortised cost

 

 

 

 

 

 

 

 

 

 

Personal Banking

173.2

169.6

161.4

 

159.2

157.9

156.3

154.1

 

154.0

Barclaycard Consumer UK

0.1

0.1

-

 

-

-

-

-

 

-

Business Banking

58.7

56.0

46.1

 

46.3

45.4

44.6

43.2

 

43.3

Total customer deposits at amortised cost

232.0

225.7

207.5

 

205.5

203.3

200.9

197.3

 

197.3

 

Barclays International

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Net interest income

823

847

998

 

965

1,059

1,017

900

 

984

Net trading income

1,528

1,660

2,360

 

929

1,110

1,016

1,144

 

837

Net fee, commission and other income

1,430

1,503

1,286

 

1,558

1,581

1,870

1,526

 

1,400

Total income

3,781

4,010

4,644

 

3,452

3,750

3,903

3,570

 

3,221

Credit impairment charges

(370)

(1,010)

(1,609)

 

(329)

(352)

(247)

(245)

 

(354)

Net operating income

3,411

3,000

3,035

 

3,123

3,398

3,656

3,325

 

2,867

Operating costs

(2,227)

(2,186)

(2,219)

 

(2,240)

(2,282)

(2,435)

(2,206)

 

(2,441)

UK bank levy

-

-

-

 

(174)

-

-

-

 

(210)

Operating expenses

(2,227)

(2,186)

(2,219)

 

(2,414)

(2,282)

(2,435)

(2,206)

 

(2,651)

Litigation and conduct

(28)

(11)

-

 

(86)

-

(11)

(19)

 

(33)

Total operating expenses

(2,255)

(2,197)

(2,219)

 

(2,500)

(2,282)

(2,446)

(2,225)

 

(2,684)

Other net income

9

4

6

 

17

21

13

18

 

32

Profit before tax

1,165

807

822

 

640

1,137

1,223

1,118

 

215

Attributable profit/(loss)

782

468

529

 

397

799

832

788

 

(21)

 

 

 

 

 

 

 

 

 

 

 

Balance sheet information

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Loans and advances at amortised cost

128.0

138.1

167.0

 

132.8

138.1

134.8

130.9

 

127.2

Trading portfolio assets

122.3

109.5

101.6

 

113.3

119.4

120.0

117.2

 

104.0

Derivative financial instrument assets

295.9

306.8

341.5

 

228.9

286.0

243.8

217.3

 

222.1

Financial assets at fair value through the income statement

178.2

154.3

188.4

 

128.4

158.0

154.7

153.5

 

144.7

Cash collateral and settlement balances

121.8

130.8

153.2

 

79.4

112.5

101.3

97.8

 

74.3

Other assets

261.7

236.3

201.5

 

178.6

195.6

196.8

202.3

 

189.8

Total assets

1,107.9

1,075.8

1,153.2

 

861.4

1,009.6

951.4

919.0

 

862.1

Deposits at amortised cost

262.4

241.2

263.3

 

210.0

217.6

212.0

215.5

 

197.2

Derivative financial instrument liabilities

293.3

307.6

338.8

 

228.9

283.3

243.0

213.5

 

219.6

Loan: deposit ratio

49%

57%

63%

 

63%

63%

64%

61%

 

65%

Risk weighted assets

224.7

231.2

237.9

 

209.2

223.1

214.8

216.1

 

210.7

Period end allocated tangible equity

30.5

31.6

33.1

 

29.6

31.4

30.2

30.6

 

29.9

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

10.2%

5.6%

6.8%

 

5.1%

9.9%

10.7%

10.4%

 

(0.3%)

Average allocated tangible equity (£bn)

30.6

33.5

31.2

 

30.9

32.2

31.1

30.5

 

31.3

Cost: income ratio

60%

55%

48%

 

72%

61%

63%

62%

 

83%

Loan loss rate (bps)

112

284

377

 

96

99

72

73

 

107

Net interest margin

3.79%

3.43%

3.93%

 

4.29%

4.10%

3.91%

3.99%

 

3.98%

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit before tax

1,193

818

822

 

726

1,137

1,234

1,137

 

248

Attributable profit

803

476

529

 

461

801

840

804

 

13

Return on average allocated tangible equity

10.5%

5.7%

6.8%

 

6.0%

10.0%

10.8%

10.6%

 

0.2%

Cost: income ratio

59%

55%

48%

 

70%

61%

62%

62%

 

82%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

 

 

 

 

Analysis of Barclays International

 

 

 

 

 

 

 

 

 

 

 

Corporate and Investment Bank

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

FICC

1,000

1,468

1,858

 

726

816

920

902

 

570

Equities

691

674

564

 

409

494

517

467

 

375

Markets

1,691

2,142

2,422

 

1,135

1,310

1,437

1,369

 

945

Advisory

90

84

155

 

202

221

221

132

 

242

Equity capital markets

122

185

62

 

56

86

104

83

 

53

Debt capital markets

398

463

418

 

322

381

373

354

 

330

Banking fees

610

732

635

 

580

688

698

569

 

625

Corporate lending

232

61

111

 

202

195

216

152

 

243

Transaction banking

372

381

449

 

397

424

444

415

 

412

Corporate

604

442

560

 

599

619

660

567

 

655

Other

-

-

-

 

-

-

-

-

 

(74)

Total income

2,905

3,316

3,617

 

2,314

2,617

2,795

2,505

 

2,151

Credit impairment charges

(187)

(596)

(724)

 

(30)

(31)

(44)

(52)

 

(35)

Net operating income

2,718

2,720

2,893

 

2,284

2,586

2,751

2,453

 

2,116

Operating costs

(1,716)

(1,680)

(1,690)

 

(1,691)

(1,712)

(1,860)

(1,619)

 

(1,835)

UK bank levy

-

-

-

 

(156)

-

-

-

 

(188)

Operating expenses

(1,716)

(1,680)

(1,690)

 

(1,847)

(1,712)

(1,860)

(1,619)

 

(2,023)

Litigation and conduct

(3)

(3)

-

 

(79)

(4)

(7)

(19)

 

(23)

Total operating expenses

(1,719)

(1,683)

(1,690)

 

(1,926)

(1,716)

(1,867)

(1,638)

 

(2,046)

Other net income

1

3

-

 

1

12

3

12

 

15

Profit before tax

1,000

1,040

1,203

 

359

882

887

827

 

85

Attributable profit/(loss)

627

694

820

 

193

609

596

582

 

(84)

 

 

 

 

 

 

 

 

 

 

 

Balance sheet information

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Loans and advances at amortised cost

96.8

104.9

128.2

 

92.0

95.8

92.1

90.6

 

86.4

Trading portfolio assets

122.2

109.3

101.5

 

113.3

119.3

119.9

117.2

 

104.0

Derivative financial instruments assets

295.9

306.7

341.4

 

228.8

286.0

243.7

217.3

 

222.1

Financial assets at fair value through the income statement

177.9

153.7

187.8

 

127.7

157.3

154.1

152.9

 

144.2

Cash collateral and settlement balances

121.0

129.7

152.2

 

78.5

111.6

100.4

96.9

 

73.4

Other assets

228.9

205.5

171.4

 

155.3

171.5

168.1

163.2

 

160.4

Total assets

1,042.7

1,009.8

1,082.5

 

795.6

941.5

878.3

838.1

 

790.5

Deposits at amortised cost

195.6

173.9

198.4

 

146.2

152.1

145.4

151.4

 

136.3

Derivative financial instrument liabilities

293.2

307.6

338.7

 

228.9

283.2

242.9

213.5

 

219.6

Risk weighted assets

193.3

198.3

201.7

 

171.5

184.9

175.9

176.6

 

170.9

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

9.5%

9.6%

12.5%

 

3.0%

9.1%

9.2%

9.3%

 

(1.3%)

Average allocated tangible equity (£bn)

26.4

29.0

26.2

 

25.8

26.9

25.8

25.1

 

26.0

Cost: income ratio

59%

51%

47%

 

83%

66%

67%

65%

 

95%

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit before tax

1,003

1,043

1,203

 

438

886

894

846

 

108

Attributable profit/(loss)

629

696

820

 

251

614

601

598

 

(57)

Return on average allocated tangible equity

9.5%

9.6%

12.5%

 

3.9%

9.2%

9.3%

9.5%

 

(0.9%)

Cost: income ratio

59%

51%

47%

 

80%

65%

67%

65%

 

94%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Analysis of Barclays International

 

 

 

 

 

 

 

 

 

 

 

Consumer, Cards and Payments

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Net interest income

518

513

663

 

717

720

720

665

 

664

Net fee, commission, trading and other income

358

181

364

 

421

413

388

400

 

406

Total income

876

694

1,027

 

1,138

1,133

1,108

1,065

 

1,070

Credit impairment charges

(183)

(414)

(885)

 

(299)

(321)

(203)

(193)

 

(319)

Net operating income

693

280

142

 

839

812

905

872

 

751

Operating costs

(511)

(506)

(529)

 

(549)

(570)

(575)

(587)

 

(606)

UK bank levy

-

-

-

 

(18)

-

-

-

 

(22)

Operating expenses

(511)

(506)

(529)

 

(567)

(570)

(575)

(587)

 

(628)

Litigation and conduct

(25)

(8)

-

 

(7)

4

(4)

-

 

(10)

Total operating expenses

(536)

(514)

(529)

 

(574)

(566)

(579)

(587)

 

(638)

Other net income

8

1

6

 

16

9

10

6

 

17

Profit/(loss) before tax

165

(233)

(381)

 

281

255

336

291

 

130

Attributable profit/(loss)

155

(226)

(291)

 

204

190

236

206

 

63

 

 

 

 

 

 

 

 

 

 

 

Balance sheet information

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Loans and advances at amortised cost

31.2

33.2

38.8

 

40.8

42.3

42.7

40.3

 

40.8

Total assets

65.2

66.0

70.7

 

65.8

68.1

73.1

80.9

 

71.6

Deposits at amortised cost

66.8

67.3

64.9

 

63.8

65.5

66.6

64.1

 

60.9

Risk weighted assets

31.4

32.9

36.2

 

37.7

38.2

38.9

39.5

 

39.8

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

14.7%

(20.2%)

(23.5%)

 

15.9%

14.2%

17.8%

15.4%

 

4.8%

Average allocated tangible equity (£bn)

4.2

4.5

5.0

 

5.1

5.3

5.3

5.4

 

5.3

Cost: income ratio

61%

74%

52%

 

50%

50%

52%

55%

 

60%

Loan loss rate (bps)

211

455

846

 

273

283

180

182

 

290

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit/(loss) before tax

190

(225)

(381)

 

288

251

340

291

 

140

Attributable profit/(loss)

174

(220)

(291)

 

210

187

239

206

 

70

Return on average allocated tangible equity

16.5%

(19.6%)

(23.5%)

 

16.3%

14.0%

18.0%

15.4%

 

5.4%

Cost: income ratio

58%

73%

52%

 

50%

50%

52%

55%

 

59%

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

 

 

Head Office

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Income statement information

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Net interest income

(48)

(180)

(79)

 

(99)

(117)

(95)

(111)

 

(201)

Net fee, commission and other income

(79)

41

14

 

(11)

62

(41)

16

 

190

Total income

(127)

(139)

(65)

 

(110)

(55)

(136)

(95)

 

(11)

Credit impairment (charges)/releases

(5)

(30)

(25)

 

(4)

(8)

(3)

(12)

 

7

Net operating expenses

(132)

(169)

(90)

 

(114)

(63)

(139)

(107)

 

(4)

Operating costs

(69)

(106)

(11)

 

(45)

(59)

(44)

(52)

 

(69)

UK bank levy

-

-

-

 

(11)

-

-

-

 

(13)

Operating expenses

(69)

(106)

(11)

 

(56)

(59)

(44)

(52)

 

(82)

GMP charge

-

-

-

 

-

-

-

-

 

(140)

Litigation and conduct

(23)

(3)

(5)

 

(23)

(88)

(1)

(39)

 

(12)

Total operating expenses

(92)

(109)

(16)

 

(79)

(147)

(45)

(91)

 

(234)

Other net income/(expenses)

10

(43)

2

 

3

6

15

(22)

 

7

Loss before tax

(214)

(321)

(104)

 

(190)

(204)

(169)

(220)

 

(231)

Attributable loss

(284)

(255)

(99)

 

(154)

(184)

(126)

(172)

 

(234)

 

 

 

 

 

 

 

 

 

 

 

Balance sheet information

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Total assets

19.3

21.7

23.6

 

21.0

22.9

22.4

21.4

 

21.5

Risk weighted assets

9.8

9.9

10.0

 

11.0

13.4

28.1

27.0

 

26.0

Period end allocated tangible equity

7.1

7.4

6.0

 

5.6

5.5

7.0

4.5

 

4.9

 

 

 

 

 

 

 

 

 

 

 

Performance measures

 

 

 

 

 

 

 

 

 

 

Average allocated tangible equity (£bn)

7.6

6.4

5.6

 

5.2

5.8

4.8

4.3

 

2.9

 

 

 

 

 

 

 

 

 

 

 

Performance measures excluding litigation and conduct1

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Loss before tax

(191)

(318)

(99)

 

(167)

(116)

(168)

(181)

 

(219)

Attributable loss

(265)

(252)

(103)

 

(139)

(118)

(124)

(144)

 

(218)

 

1

Refer to pages 40 to 49 for further information and calculations of performance measures excluding litigation and conduct.

 

Performance Management

 

Margins and balances

 

 

 

 

 

 

 

Nine months ended 30.09.20

Nine months ended 30.09.19

 

Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin

 

£m

£m

%

£m

£m

%

Barclays UK

3,917

199,048

 2.63

4,410

189,994

 3.10

Barclays International1

2,686

96,799

 3.71

2,985

99,862

 4.00

Total Barclays UK and Barclays International

6,603

295,847

 2.98

7,395

289,856

 3.41

Other2

(325)

 

 

(332)

 

 

Total Barclays Group

6,278

 

 

7,063

 

 

 

1

Barclays International margins include interest earning lending balances within the investment banking business.

2

Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins.

 

The Group's combined product and equity structural hedge notional as at 30 September 2020 was £181bn, with an average duration of 2.5 to 3 years. Group net interest income includes gross structural hedge contributions of £1.3bn (Q319 YTD: £1.4bn) and net structural hedge contributions of £0.9bn (Q319 YTD: £0.4bn). Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.

 

Quarterly analysis for Barclays UK and Barclays International

Net interest income

Average customer assets

Net interest margin

Three months ended 30.09.20

£m

£m

%

Barclays UK

 1,280

 203,089

 2.51

Barclays International1

 838

 88,032

 3.79

Total Barclays UK and Barclays International

 2,118

 291,121

 2.89

 

 

 

 

Three months ended 30.06.20

 

 

 

Barclays UK

1,225

199,039

2.48

Barclays International1

868

101,706

3.43

Total Barclays UK and Barclays International

2,093

300,745

2.80

 

 

 

 

Three months ended 31.03.20

 

 

 

Barclays UK

1,412

195,204

2.91

Barclays International1

980

100,171

3.93

Total Barclays UK and Barclays International

2,392

295,375

3.26

 

 

 

 

Three months ended 31.12.19

 

 

 

Barclays UK

1,478

193,610

3.03

Barclays International1

1,036

95,819

4.29

Total Barclays UK and Barclays International

2,514

289,429

3.45

 

 

 

 

Three months ended 30.09.19

 

 

 

Barclays UK

1,503

192,262

3.10

Barclays International1

1,038

100,589

4.10

Total Barclays UK and Barclays International

2,541

292,851

3.44

 

1

Barclays International margins include interest earning lending balances within the investment banking business.

 

Credit Risk

 

Loans and advances at amortised cost by stage

 

The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 30 September 2020. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 30 September 2020.

 

Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.

 

 

Gross exposure

 

Impairment allowance

Net exposure

 

Stage 1

Stage 2

Stage 3

Total

 

Stage 1

Stage 2

Stage 3

Total

As at 30.09.20

£m

£m

£m

£m

 

£m

£m

£m

£m

£m

Barclays UK

149,393

25,846

2,704

177,943

 

329

1,563

1,150

3,042

174,901

Barclays International

16,866

5,366

1,691

23,923

 

412

1,296

1,275

2,983

20,940

Head Office

4,519

668

871

6,058

 

8

53

352

413

5,645

Total Barclays Group retail

170,778

31,880

5,266

207,924

 

749

2,912

2,777

6,438

201,486

Barclays UK

30,540

3,887

1,138

35,565

 

58

98

143

299

35,266

Barclays International

74,789

31,775

2,422

108,986

 

129

793

1,002

1,924

107,062

Head Office

595

 -

34

629

 

 -

 -

33

33

596

Total Barclays Group wholesale1

105,924

35,662

3,594

145,180

 

187

891

1,178

2,256

142,924

Total loans and advances at amortised cost

276,702

67,542

8,860

353,104

 

936

3,803

3,955

8,694

344,410

Off-balance sheet loan commitments and financial guarantee contracts2

282,551

65,407

1,500

349,458

 

138

751

46

935

348,523

Total3

559,253

132,949

10,360

702,562

 

1,074

4,554

4,001

9,629

692,933

 

 

 

 

 

 

 

 

 

 

 

 

As at 30.09.20

 

Period ended 30.09.20

 

 

Coverage ratio

 

Loan impairment charge and loan loss rate4

 

 

Stage 1

Stage 2

Stage 3

Total

 

Loan impairment charge

Loan loss rate

 

 

%

%

%

%

 

£m

bps

 

Barclays UK

0.2

6.0

42.5

1.7

 

 

966

 

73

 

Barclays International

2.4

24.2

75.4

12.5

 

 

1,423

 

795

 

Head Office

0.2

7.9

40.4

6.8

 

 

60

 

132

 

Total Barclays Group retail

0.4

9.1

52.7

3.1

 

 

2,449

 

157

 

Barclays UK

0.2

2.5

12.6

0.8

 

 

174

 

65

 

Barclays International

0.2

2.5

41.4

1.8

 

 

954

 

117

 

Head Office

-

-

97.1

5.2

 

 

 -

 

 -

 

Total Barclays Group wholesale1

0.2

2.5

32.8

1.6

 

 

1,128

 

104

 

Total loans and advances at amortised cost

0.3

5.6

44.6

2.5

 

 

3,577

 

135

 

Off-balance sheet loan commitments and financial guarantee contracts2

-

1.1

3.1

0.3

 

 

627

 

 

 

Other financial assets subject to impairment3

 

 

 

 

 

 

142

 

 

 

Total4

0.2

3.4

38.6

1.4

 

 

4,346

 

 

 

 

1

Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £701m of balances reported as wholesale loans on page 25 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £8.6bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.8bn and impairment allowance of £161m. This comprises £13m ECL on £192.1bn stage 1 assets, £38m on £5.6bn stage 2 fair value through other comprehensive income assets, other assets, cash collateral and settlement balances and £110m on £112m stage 3 other assets.

4

Q320 YTD loan impairment charge represents nine months of impairment charge, annualised to calculate the loan loss rate. The loan loss rate for Q320 YTD is 164bps after applying the total impairment charge of £4,346m.

 

 

Gross exposure

 

Impairment allowance

Net exposure

 

Stage 1

Stage 2

Stage 3

Total

 

Stage 1

Stage 2

Stage 3

Total

As at 31.12.19

£m

£m

£m

£m

 

£m

£m

£m

£m

£m

Barclays UK

143,097

23,198

2,446

168,741

 

198

1,277

974

2,449

166,292

Barclays International

27,886

4,026

1,875

33,787

 

352

774

1,359

2,485

31,302

Head Office

4,803

500

826

6,129

 

5

36

305

346

5,783

Total Barclays Group retail

175,786

27,724

5,147

208,657

 

555

2,087

2,638

5,280

203,377

Barclays UK

27,891

2,397

1,124

31,412

 

16

38

108

162

31,250

Barclays International

92,615

8,113

1,615

102,343

 

136

248

447

831

101,512

Head Office

2,974

-

37

3,011

 

-

-

35

35

2,976

Total Barclays Group wholesale1

123,480

10,510

2,776

136,766

 

152

286

590

1,028

135,738

Total loans and advances at amortised cost

299,266

38,234

7,923

345,423

 

707

2,373

3,228

6,308

339,115

Off-balance sheet loan commitments and financial guarantee contracts2

321,140

19,185

935

341,260

 

97

170

55

322

340,938

Total3

620,406

57,419

8,858

686,683

 

804

2,543

3,283

6,630

680,053

 

 

 

 

 

 

 

 

 

 

 

 

As at 31.12.19

 

Year ended 31.12.19

 

 

Coverage ratio

 

Loan impairment charge and loan loss rate4

 

 

Stage 1

Stage 2

Stage 3

Total

 

Loan impairment charge

Loan loss rate

 

 

%

%

%

%

 

£m

 

bps

 

Barclays UK

0.1

5.5

39.8

1.5

 

 

661

 

39

 

Barclays International

1.3

19.2

72.5

7.4

 

 

999

 

296

 

Head Office

0.1

7.2

36.9

5.6

 

 

27

 

44

 

Total Barclays Group retail

0.3

7.5

51.3

2.5

 

 

1,687

 

81

 

Barclays UK

0.1

1.6

9.6

0.5

 

 

33

 

11

 

Barclays International

0.1

3.1

27.7

0.8

 

 

113

 

11

 

Head Office

-

-

94.6

1.2

 

 

-

 

-

 

Total Barclays Group wholesale1

0.1

2.7

21.3

0.8

 

 

146

 

11

 

Total loans and advances at amortised cost

0.2

6.2

40.7

1.8

 

 

1,833

 

53

 

Off-balance sheet loan commitments and financial guarantee contracts2

-

0.9

5.9

0.1

 

 

71

 

 

 

Other financial assets subject to impairment3

 

 

 

 

 

 

8

 

 

 

Total4

0.1

4.4

37.1

1.0

 

 

1,912

 

 

 

 

1

Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £6,434m of balances reported as wholesale loans on page 25 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £17.7bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £149.3bn and impairment allowance of £24m. This comprises £12m ECL on £148.5bn stage 1 assets, £2m on £0.8bn stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £10m on £10m stage 3 other assets.

4

The loan loss rate is 55bps after applying the total impairment charge of £1,912m.

 

Loans and advances at amortised cost by product

 

The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.

 

 

 

Stage 2

 

 

As at 30.09.20

Stage 1

Not past due

>30 days past due

Total

Stage 3

Total

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

135,995

17,262

1,843

969

20,074

2,234

158,303

Credit cards, unsecured loans and other retail lending

33,815

11,005

483

273

11,761

3,344

48,920

Wholesale loans

106,892

31,887

3,275

545

35,707

3,282

145,881

Total

276,702

60,154

5,601

1,787

67,542

8,860

353,104

 

 

 

 

 

 

 

 

Impairment allowance

 

 

 

 

 

 

 

Home loans

20

62

11

12

85

392

497

Credit cards, unsecured loans and other retail lending

754

2,461

164

173

2,798

2,423

5,975

Wholesale loans

162

821

92

7

920

1,140

2,222

Total

936

3,344

267

192

3,803

3,955

8,694

 

 

 

 

 

 

 

 

Net exposure

 

 

 

 

 

 

 

Home loans

135,975

17,200

1,832

957

19,989

1,842

157,806

Credit cards, unsecured loans and other retail lending

33,061

8,544

319

100

8,963

921

42,945

Wholesale loans

106,730

31,066

3,183

538

34,787

2,142

143,659

Total

275,766

56,810

5,334

1,595

63,739

4,905

344,410

 

 

 

 

 

 

 

 

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.4

0.6

1.2

0.4

17.5

0.3

Credit cards, unsecured loans and other retail lending

2.2

22.4

34.0

63.4

23.8

72.5

12.2

Wholesale loans

0.2

2.6

2.8

1.3

2.6

34.7

1.5

Total

0.3

5.6

4.8

10.7

5.6

44.6

2.5

 

 

 

 

 

 

 

 

As at 31.12.19

 

 

 

 

 

 

 

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

135,713

14,733

1,585

725

17,043

2,155

154,911

Credit cards, unsecured loans and other retail lending

46,012

9,759

496

504

10,759

3,409

60,180

Wholesale loans

117,541

9,374

374

684

10,432

2,359

130,332

Total

299,266

33,866

2,455

1,913

38,234

7,923

345,423

 

 

 

 

 

 

 

 

Impairment allowance

 

 

 

 

 

 

 

Home loans

22

37

14

13

64

346

432

Credit cards, unsecured loans and other retail lending

542

1,597

159

251

2,007

2,335

4,884

Wholesale loans

143

284

9

9

302

547

992

Total

707

1,918

182

273

2,373

3,228

6,308

 

 

 

 

 

 

 

 

Net exposure

 

 

 

 

 

 

 

Home loans

135,691

14,696

1,571

712

16,979

1,809

154,479

Credit cards, unsecured loans and other retail lending

45,470

8,162

337

253

8,752

1,074

55,296

Wholesale loans

117,398

9,090

365

675

10,130

1,812

129,340

Total

298,559

31,948

2,273

1,640

35,861

4,695

339,115

 

 

 

 

 

 

 

 

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.3

0.9

1.8

0.4

16.1

0.3

Credit cards, unsecured loans and other retail lending

1.2

16.4

32.1

49.8

18.7

68.5

8.1

Wholesale loans

0.1

3.0

2.4

1.3

2.9

23.2

0.8

Total

0.2

5.7

7.4

14.3

6.2

40.7

1.8

 

The number of customers who remain on payment holidays granted in response to the pandemic continues to fall. Across the Group's material portfolios as at 30 September 2020, c.£4.4bn of UK mortgage, c.£0.1bn of UK credit card and c.£0.1bn of US credit card lending remained on payment holidays.

 

Measurement uncertainty

 

Scenarios used to calculate the Group's ECL charge were reviewed and updated in September 2020 with the Baseline scenario reflecting the latest consensus economic forecasts. Changes in the consensus Baseline forecasts since June 2020 include a more prolonged period of high unemployment in the UK but faster reduction in US unemployment levels in the short term. Economic growth in the UK and the US begins to recover in 2021 in the downside scenarios. In the upside scenarios, the strong rebound in UK and US GDP continues into the end of 2020, following the bounce-back in growth in Q320 and, subsequently, the projections stay above the year on year growth rates seen in the Baseline for a prolonged period of time before finally reverting to the long term run rate. This reflects the assumption of a potential vaccine being available in the first half of 2021 and pent up savings being deployed into a more certain consumer environment to drive significant growth. Scenario weights have been updated to reflect the latest economics.

 

As a result of government and Barclays support measures put in place to support customers and clients, significant credit deterioration has not yet occurred. This support is causing a timing difference between economic drivers such as GDP and unemployment rates, and the resultant impairment defaults. This is expected to delay the effects of distress and therefore increases uncertainty on the timing of the stress and the realisation of defaults. The Q320 review did not identify any new information to substantiate a change in the level of expected credit losses on non-defaulted positions from that recognised at H120. This has led to the maintenance of coverage levels and staging mix whilst recognising the associated ECL charge on defaults that have arisen in the quarter.

 

The economic environment remains uncertain and future impairment charges may be subject to further volatility (including from changes to macroeconomic variable forecasts) depending on the longevity of the COVID-19 pandemic and related containment measures, as well as the longer term effectiveness of central bank, government and other support measures.

 

The tables below show the key consensus macroeconomic variables used in the Q320 Baseline scenario and the probability weights applied to each scenario.

 

Baseline average macroeconomic variables used in the calculation of ECL

 

2020

2021

2022

Expected Worst Point

As at 30.09.20

 %

 %

%

 %

UK GDP1

(10.3)

6.2

3.3

(59.8)

UK unemployment2

5.5

6.9

6.2

8.1

UK HPI3

0.4

1.5

1.4

(0.9)

UK bank rate

0.2

(0.1)

(0.1)

(0.1)

US GDP1

(4.4)

3.8

3.0

(32.9)

US unemployment4

8.4

6.9

5.6

13.0

US HPI5

1.8

1.8

2.9

0.7

US federal funds rate

0.5

0.3

0.3

0.1

 

 

 

 

 

As at 30.06.20

 

 

 

 

UK GDP1

(8.7)

6.1

2.9

(51.4)

UK unemployment2

6.6

6.5

4.4

8.0

UK HPI3

0.6

2.0

-

(1.5)

UK bank rate

0.2

0.1

0.1

0.1

US GDP1

(4.2)

4.4

(0.3)

(30.4)

US unemployment4

9.3

7.6

5.5

13.4

US HPI5

1.1

1.8

(0.8)

(1.9)

US federal funds rate

0.5

0.3

0.3

0.3

 

1

Average Real GDP seasonally adjusted change in year; expected worst point is the minimum seasonally adjusted quarterly annualised rate.

2

Average UK unemployment rate 16-year+.

3

Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end; worst point is based on cumulative drawdown in year relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in average yearly US HPI = FHFA house price index, relative to prior year end; worst point is based on cumulative drawdown in year relative to prior year end.

 

Scenario probability weighting

 

 

 

 

 

 

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

 

 %

 %

 %

 %

 %

As at 30.09.20

 

 

 

 

 

Scenario probability weighting

20.1

21.6

23.5

19.2

15.6

As at 30.06.20

 

 

 

 

 

Scenario probability weighting

20.3

22.4

25.4

17.5

14.4

As at 31.12.19

 

 

 

 

 

Scenario probability weighting

10.1

23.1

40.8

22.7

3.3

 

Treasury and Capital Risk

 

Composition of the Group liquidity pool

 

As at 30.09.20

As at 31.12.19

 

Liquidity pool

Liquidity pool of which CRR LCR eligible3

Liquidity pool

 

Cash

Level 1

Level 2A

 

£bn

£bn

£bn

£bn

£bn

Cash and deposits with central banks1

248

243

-

-

153

 

 

 

 

 

 

Government bonds2

 

 

 

 

 

AAA to AA-

32

-

31

1

31

A+ to A-

18

-

11

7

2

BBB+ to BBB-

2

-

2

-

3

Total government bonds

52

-

44

8

36

 

 

 

 

 

 

Other

 

 

 

 

 

Government guaranteed issuers, PSEs and GSEs

10

-

8

1

9

International organisations and MDBs

8

-

8

-

7

Covered bonds

8

-

6

2

6

Other

1

-

-

-

-

Total other

27

-

22

3

22

 

 

 

 

 

 

Total as at 30 September 2020

327

243

66

11

211

Total as at 31 December 2019

211

150

50

3

 

 

1

Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99% (December 2019: over 98%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.

2

Of which over 77% (December 2019: over 67%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.

3

The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II) qualifying assets that are not eligible under Barclays' internal risk appetite.

 

The Group liquidity pool increased to £327bn as at 30 September 2020 (December 2019: £211bn) driven by a 19% growth in customer deposit and actions to maintain a prudent funding and liquidity position in the current environment. The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.

 

The composition of the pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.

 

Capital

 

The Group's Overall Capital Requirement for CET1 is 11.3% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.8% Pillar 2A requirement and a 0.0% Countercyclical Capital Buffer (CCyB).

 

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group.

 

The Group's Pillar 2A requirement as per the PRA's Individual Capital Requirement is 5.0% of which at least 56.25% needs to be met with CET1 capital, equating to approximately 2.8% of RWAs. The Pillar 2A requirement is subject to at least annual review and has been set as a nominal capital amount. This is based on a point in time assessment and the requirement (when expressed as a proportion of RWAs) will change depending on the total RWAs at each reporting period. 

 

On 27 June 2019, CRR II came into force amending CRR. As an amending regulation, the existing provisions of CRR apply unless they are amended by CRR II. Certain aspects of CRR II are dependent on final technical standards to be issued by the European Banking Authority (EBA) and adopted by the European Commission as well as UK implementation of the rules. 

 

On 27 June 2020, CRR was further amended to accelerate specific CRR II measures and implement a new IFRS 9 transitional relief calculation. Previously due to be implemented in June 2021, the accelerated measures primarily relate to the CRR leverage calculation to include additional settlement netting and limited changes to the calculation of RWAs. For UK leverage calculations, the PRA early adopted the CRR II settlement netting measure in April 2020.

 

The IFRS 9 transitional arrangements have been extended by two years and a new modified calculation has been introduced. 100% relief will be applied to increases in stage 1 and stage 2 provisions from 1 January 2020 throughout 2020 and 2021; 75% in 2022; 50% in 2023; 25% in 2024 with no relief applied from 2025. The phasing out of transitional relief on the "day 1" impact of IFRS 9 as well as increases in stage 1 and stage 2 provisions between 1 January 2018 and 31 December 2019 under the modified calculation remain unchanged and continue to be subject to 70% transitional relief throughout 2020; 50% for 2021; 25% for 2022 and with no relief applied from 2023.

 

On 22 April 2020, the regulatory technical standards on prudent valuation were amended to include an increase to diversification factors applied to certain additional valuation adjustments. The amendments will also impact own funds and will apply until 31 December 2020 inclusive.

 

The disclosures in the following section reflect Barclays' interpretation of the current rules and guidance.

 

Capital ratios1,2,3

As at

As at

As at

30.09.20

30.06.20

31.12.19

CET1

14.6%

14.2%

13.8%

Tier 1 (T1)

18.7%

17.8%

17.7%

Total regulatory capital

22.5%

21.7%

21.6%

 

 

 

Capital resources

£m

£m

£m

Total equity excluding non-controlling interests per the balance sheet

67,816

68,304

64,429

Less: other equity instruments (recognised as AT1 capital)

(12,012)

(10,871)

(10,871)

Adjustment to retained earnings for foreseeable dividends

(65)

(44)

(1,096)

 

 

 

 

Other regulatory adjustments and deductions

 

 

 

Additional value adjustments (PVA)

(1,241)

(1,517)

(1,746)

Goodwill and intangible assets

(8,154)

(8,154)

(8,109)

Deferred tax assets that rely on future profitability excluding temporary differences

(422)

(444)

(479)

Fair value reserves related to gains or losses on cash flow hedges

(1,745)

(1,914)

(1,002)

Gains or losses on liabilities at fair value resulting from own credit

717

(233)

260

Defined benefit pension fund assets

(1,785)

(2,094)

(1,594)

Direct and indirect holdings by an institution of own CET1 instruments

(50)

(50)

(50)

Adjustment under IFRS 9 transitional arrangements

2,512

2,459

1,126

Other regulatory adjustments

(62)

(62)

(55)

CET1 capital

45,509

45,380

40,813

  

 

 

 

AT1 capital

 

 

 

Capital instruments and related share premium accounts

12,012

10,871

10,871

Qualifying AT1 capital (including minority interests) issued by subsidiaries

622

691

687

Other regulatory adjustments and deductions

(80)

(80)

(130)

AT1 capital

12,554

11,482

11,428

 

 

 

 

T1 capital

58,063

56,862

52,241

 

 

 

T2 capital

 

 

 

Capital instruments and related share premium accounts

9,451

9,028

7,650

Qualifying T2 capital (including minority interests) issued by subsidiaries

2,516

3,396

3,984

Credit risk adjustments (excess of impairment over expected losses)

36

36

16

Other regulatory adjustments and deductions

(160)

(160)

(250)

Total regulatory capital

69,906

69,162

63,641

 

 

 

 

Total RWAs

310,727

318,987

295,131

 

1

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.

2

The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.9%, with £43.0bn of CET1 capital and £309.8bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date.

3

The Barclays PLC CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC T2 Contingent Capital Notes, was 14.6%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017.

 

Movement in CET1 capital

Three months

Nine months

ended

ended

30.09.20

30.09.20

£m

£m

Opening CET1 capital

45,380

40,813

 

 

 

Profit for the period attributable to equity holders

815

1,937

Own credit relating to derivative liabilities

16

19

Dividends paid and foreseen

(225)

400

Increase in retained regulatory capital generated from earnings

606

2,356

 

 

 

Net impact of share schemes

(268)

20

Fair value through other comprehensive income reserve

173

(205)

Currency translation reserve

(716)

504

Other reserves

(3)

(6)

(Decrease) / increase in other qualifying reserves

(814)

313

 

 

 

Pension remeasurements within reserves

(323)

322

Defined benefit pension fund asset deduction

309

(191)

Net impact of pensions

(14)

131

 

 

 

Additional value adjustments (PVA)

276

505

Goodwill and intangible assets

-

(45)

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

22

57

Adjustment under IFRS 9 transitional arrangements

53

1,386

Other regulatory adjustments

-

(7)

Increase in regulatory capital due to adjustments and deductions

351

1,896

 

 

 

Closing CET1 capital

45,509

45,509

 

 

 

 

CET1 capital increased £4.7bn to £45.5bn (December 2019: £40.8bn).

 

£1.9bn of capital generated from profits, and a £1.0bn increase due to the cancellation of the full year 2019 dividend were partially offset by £0.6bn of AT1 coupons paid. Other significant movements in the period were:

 

·

A £0.5bn increase in the currency translation reserve mainly driven by the appreciation of period end USD and EUR against GBP

·

A £0.5bn increase due to a reduction in PVA which includes the temporary increase to diversification factors applied to certain additional valuation adjustments

·

A £1.4bn increase in the IFRS 9 transitional relief after tax, following new impairment charges and the implementation of new regulatory measures which allow for 100% relief on increases in stage 1 and stage 2 impairment throughout 2020 and 2021

 

RWAs by risk type and business

 

Credit risk

 

Counterparty credit risk

 

Market risk

 

Operational risk

Total RWAs

 

Std

IRB

 

Std

IRB

Settlement risk

CVA

 

Std

IMA

 

 

 

As at 30.09.20

£m

£m

 

£m

£m

£m

£m

 

£m

£m

 

£m

£m

Barclays UK

7,350

56,373

 

369

-

-

100

 

125

-

 

11,851

76,168

Corporate and Investment Bank

24,800

76,464

 

11,628

20,645

106

2,545

 

13,043

22,709

 

21,388

193,328

Consumer, Cards and Payments

20,597

2,921

 

168

47

-

35

 

-

75

 

7,538

31,381

Barclays International

45,397

79,385

 

11,796

20,692

106

2,580

 

13,043

22,784

 

28,926

224,709

Head Office

3,701

6,022

 

-

-

-

-

 

-

-

 

127

9,850

Barclays Group

56,448

141,780

 

12,165

20,692

106

2,680

 

13,168

22,784

 

40,904

310,727

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at 30.06.20

 

 

 

 

 

 

 

 

 

 

 

 

 

Barclays UK

7,428

58,048

 

359

 -

 -

48

 

122

 -

 

11,851

77,856

Corporate and Investment Bank

27,032

77,983

 

11,879

20,472

218

3,871

 

12,830

22,638

 

21,387

198,310

Consumer, Cards and Payments

21,901

3,168

 

157

46

 -

27

 

 -

95

 

7,539

32,933

Barclays International

48,933

81,151

 

12,036

20,518

218

3,898

 

12,830

22,733

 

28,926

231,243

Head Office

3,578

6,183

 

 -

 -

 -

 -

 

 -

-

 

127

9,888

Barclays Group

59,939

145,382

 

12,395

20,518

218

3,946

 

12,952

22,733

 

40,904

318,987

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at 31.12.19

 

 

 

 

 

 

 

 

 

 

 

 

 

Barclays UK

5,189

57,455

 

235

-

-

23

 

178

-

 

11,821

74,901

Corporate and Investment Bank

25,749

62,177

 

12,051

16,875

276

2,470

 

12,854

17,626

 

21,475

171,553

Consumer, Cards and Payments

27,209

2,706

 

92

37

-

11

 

-

103

 

7,532

37,690

Barclays International

52,958

64,883

 

12,143

16,912

276

2,481

 

12,854

17,729

 

29,007

209,243

Head Office

5,104

5,754

 

-

-

-

-

 

-

-

 

129

10,987

Barclays Group

63,251

128,092

 

12,378

16,912

276

2,504

 

13,032

17,729

 

40,957

295,131

 

Movement analysis of RWAs

 

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

 

£m

£m

£m

£m

£m

Opening RWAs (as at 31.12.19)

191,343

32,070

30,761

40,957

295,131

Book size

(4,793)

1,963

10,031

(53)

7,148

Acquisitions and disposals

(119)

-

-

-

(119)

Book quality

9,792

1,112

-

-

10,904

Model updates

1,933

(50)

-

-

1,883

Methodology and policy

(1,879)

548

(4,840)

-

(6,171)

Foreign exchange movements1

1,951

-

-

-

1,951

Total RWA movements

6,885

3,573

5,191

(53)

15,596

Closing RWAs (as at 30.09.20)

198,228

35,643

35,952

40,904

310,727

 

1

Foreign exchange movements do not include foreign exchange for counterparty credit risk or market risk.

 

Overall RWAs increased £15.6bn mainly driven by:

 

Credit risk RWAs increased £6.9bn mainly due to:

·

Book size decreased RWAs £4.8bn primarily due to a reduction in lending activities, repayments and lower IEL balances

·

Book quality increased RWAs £9.8bn mainly due to a reduction in credit quality primarily within CIB

·

Model updates increased RWAs £1.9bn primarily due to modelled risk weight recalibrations

·

Methodology and policy decreased RWAs £1.9bn primarily due the application of revised SME discount factors following the early adoption of specific CRR II measures

·

FX increased RWAs £2.0bn due to the appreciation of period end USD against GBP

 

Counterparty credit risk RWAs increased £3.6bn mainly due to:

·

Book size increased RWAs £2.0bn primarily due to an increase in trading activities across SFTs and derivatives

·

Book quality increased RWAs £1.1bn primarily due to a reduction in credit quality within CIB

 

Market risk RWAs increased £5.2bn mainly due to:

·

Book size increased RWAs £10.0bn primarily due to an increase in trading activities and higher market volatility

·

Methodology and policy decreased RWAs £4.8bn primarily due to the removal of a Risk Not In VaR (RNIV) and a reduction in pre COVID-19 VaR back testing exceptions

 

Leverage ratio and exposures

 

The Group is subject to a leverage ratio requirement of 3.8% as at 30 September 2020. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.0%. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £5.8bn.

 

The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage ratio based on capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central banks from the leverage exposures and include the PRA's early adoption of CRR II settlement netting.

 

Leverage ratios1,2

As at

30.09.20

As at

30.06.20

As at

31.12.19

£m

£m

£m

Average UK leverage ratio

5.1%

4.7%

4.5%

Average T1 capital3

56,690

54,548

51,823

Average UK leverage exposure

1,111,052

1,148,720

1,142,819

 

 

 

 

UK leverage ratio

5.2%

5.2%

5.1%

 

 

 

 

CET1 capital

45,509

45,380

40,813

AT1 capital

11,932

10,791

10,741

T1 capital3

57,441

56,171

51,554

 

 

 

 

UK leverage exposure

1,095,097

1,071,138

1,007,721

 

 

 

 

UK leverage exposure

 

 

 

Accounting assets

 

 

 

Derivative financial instruments

296,551

307,258

229,236

Derivative cash collateral

67,034

77,063

56,589

Securities financing transactions (SFTs)

178,736

160,015

111,307

Loans and advances and other assets

879,348

840,781

743,097

Total IFRS assets

1,421,669

1,385,117

1,140,229

 

 

 

 

Regulatory consolidation adjustments

(1,943)

(1,982)

(1,170)

 

 

 

 

Derivatives adjustments

 

 

 

Derivatives netting

(269,441)

(279,151)

(207,756)

Adjustments to cash collateral

(58,298)

(67,718)

(48,464)

Net written credit protection

15,890

14,442

13,784

Potential future exposure (PFE) on derivatives

122,426

123,468

119,118

Total derivatives adjustments

(189,423)

(208,959)

(123,318)

 

 

 

 

SFTs adjustments

20,274

21,226

18,339

 

 

 

 

Regulatory deductions and other adjustments

(18,011)

(18,297)

(11,984)

 

 

 

 

Weighted off-balance sheet commitments

110,749

108,436

105,289

 

 

 

 

Qualifying central bank claims

(205,451)

(173,033)

(119,664)

 

 

 

 

Settlement netting

(42,767)

(41,370)

-

 

 

 

 

UK leverage exposure2

1,095,097

1,071,138

1,007,721

 

1

Fully loaded average UK leverage ratio was 4.9%, with £54.2bn of T1 capital and £1,109bn of leverage exposure. Fully loaded UK leverage ratio was 5.0%, with £54.9bn of T1 capital and £1,093bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date.

2

Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date.

3

T1 capital is calculated in line with the PRA Handbook.

 

The average UK leverage ratio increased to 5.1% (December 2019: 4.5%), driven by an increase in T1 capital. The leverage exposure decreased by £32bn to £1,111bn, primarily driven by the PRA's early adoption of CRR II settlement netting.

 

The UK leverage ratio increased to 5.2% (December 2019: 5.1%), driven by an increase in T1 capital. The UK leverage exposure increased by £87bn to £1,095bn, primarily driven by an increase in SFTs of £67bn. Loans, advances and other assets increase of £136bn was broadly offset by qualifying central bank claims and the PRA's early adoption of CRR II settlement netting.

 

The Group also discloses a CRR leverage ratio1 within its additional regulatory disclosures prepared in accordance with EBA guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report Q3 2020, expected to be published on 23 October 2020 and which will be available at home.barclays/investor-relations/reports-and-events/latest-financial-results).

 

1

CRR leverage ratio as amended by CRR II applicable as at the reporting date.

 

MREL

 

CRR II requirements relating to own funds and eligible liabilities came into effect from 27 June 2019. Eligible liabilities have been calculated reflecting the Group's interpretation of the current rules and guidance. Certain aspects of CRR II are dependent on final technical standards to be issued by the EBA and adopted by the European Commission as well as UK implementation of the rules.

 

The Group is required to meet the higher of: (i) the MREL set by the Bank of England; and (ii) the requirements in CRR II, both of which have RWA and leverage based requirements. MREL is subject to phased implementation and will be fully implemented by 1 January 2022, at which time the Group's indicative MREL is expected to be two times the sum of its Pillar 1 and Pillar 2A requirements, as set by the Bank of England. In addition, CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above both the Pillar 1 and Pillar 2A requirements relating to own funds and eligible liabilities. The Bank of England will review the MREL calibration by the end of 2020, including assessing the proposal for Pillar 2A recapitalisation, which may drive a different 1 January 2022 MREL than currently proposed.

 

Own funds and eligible liabilities ratios1

As at

30.09.20

As at

30.06.20

As at

31.12.19

CET1 capital

14.6%

14.2%

13.8%

AT1 capital instruments and related share premium accounts2

3.8%

3.4%

3.6%

T2 capital instruments and related share premium accounts2

3.0%

2.8%

2.5%

Eligible liabilities

11.3%

12.0%

11.2%

Total Barclays PLC (the Parent company) own funds and eligible liabilities

32.8%

32.4%

31.2%

Qualifying AT1 capital (including minority interests) issued by subsidiaries

0.2%

0.2%

0.2%

Qualifying T2 capital (including minority interests) issued by subsidiaries

0.8%

1.1%

1.3%

Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments

33.8%

33.7%

32.8%

 

 

 

 

Own funds and eligible liabilities1

£m

£m

£m

CET1 capital

45,509

45,380

40,813

AT1 capital instruments and related share premium accounts2

11,932

10,791

10,741

T2 capital instruments and related share premium accounts2

9,327

8,904

7,416

Eligible liabilities

35,209

38,308

33,025

Total Barclays PLC (the Parent company) own funds and eligible liabilities

101,977

103,383

91,995

Qualifying AT1 capital (including minority interests) issued by subsidiaries

622

691

687

Qualifying T2 capital (including minority interests) issued by subsidiaries

2,516

3,396

3,984

Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments

105,115

107,470

96,666

 

 

 

 

Total RWAs1

310,727

318,987

295,131

 

1

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.

2

Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2019: £130m), and other T2 credit risk adjustments and deductions of £124m (December 2019: £234m).

 

Condensed Consolidated Financial Statements

 

Condensed consolidated income statement

 

 

Nine months ended

Nine months ended

 

 

30.09.20

30.09.19

 

 

£m

£m

Total income

 

16,825

16,331

Credit impairment charges

 

(4,346)

(1,389)

Net operating income

 

12,479

14,942

Operating expenses excluding litigation and conduct

 

(9,954)

(10,051)

Litigation and conduct

 

(106)

(1,682)

Operating expenses

 

(10,060)

(11,733)

Other net income

 

-

51

Profit before tax

 

2,419

3,260

Tax charge

 

(441)

(814)

Profit after tax

 

1,978

2,446

 

 

 

 

Attributable to:

 

 

 

Equity holders of the parent

 

1,306

1,780

Other equity instrument holders

 

631

628

Total equity holders of the parent

 

1,937

2,408

Non-controlling interests

 

41

38

Profit after tax

 

1,978

2,446

 

 

 

 

Earnings per share

 

p

p

Basic earnings per ordinary share

 

7.6

10.4

 

Condensed consolidated balance sheet

 

 

As at

As at

 

 

30.09.20

31.12.19

Assets

 

£m

£m

Cash and balances at central banks

 

240,973

150,258

Cash collateral and settlement balances

 

125,413

83,256

Loans and advances at amortised cost

 

344,410

339,115

Reverse repurchase agreements and other similar secured lending

 

15,436

3,379

Trading portfolio assets

 

122,741

114,195

Financial assets at fair value through the income statement

 

182,760

133,086

Derivative financial instruments

 

296,551

229,236

Financial assets at fair value through other comprehensive income

 

71,289

65,750

Investments in associates and joint ventures

 

741

721

Goodwill and intangible assets

 

8,163

8,119

Current tax assets

 

630

412

Deferred tax assets

 

2,929

3,290

Other assets

 

9,633

9,412

Total assets

 

1,421,669

1,140,229

 

 

 

 

Liabilities

 

 

 

Deposits at amortised cost

 

494,593

415,787

Cash collateral and settlement balances

 

112,532

67,341

Repurchase agreements and other similar secured borrowing

 

20,972

14,517

Debt securities in issue

 

98,688

76,369

Subordinated liabilities

 

20,259

18,156

Trading portfolio liabilities

 

51,075

36,916

Financial liabilities designated at fair value

 

249,322

204,326

Derivative financial instruments

 

293,446

229,204

Current tax liabilities

 

454

313

Deferred tax liabilities

 

-

23

Other liabilities

 

11,271

11,617

Total liabilities

 

1,352,612

1,074,569

 

 

 

 

Equity

 

 

 

Called up share capital and share premium

 

4,630

4,594

Other reserves

 

5,349

4,760

Retained earnings

 

45,825

44,204

Shareholders' equity attributable to ordinary shareholders of the parent

 

55,804

53,558

Other equity instruments

 

12,012

10,871

Total equity excluding non-controlling interests

 

67,816

64,429

Non-controlling interests

 

1,241

1,231

Total equity

 

69,057

65,660

 

 

 

 

Total liabilities and equity

 

1,421,669

1,140,229

 

Condensed consolidated statement of changes in equity

 

Called up share capital and share premium

Other equity instruments

Other reserves

Retained earnings

Total

Non-controlling interests

Total equity

Nine months ended 30.09.20

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 January 2020

4,594

10,871

4,760

44,204

64,429

1,231

65,660

Profit after tax

-

631

-

1,306

1,937

41

1,978

Retirement benefit remeasurements

-

-

-

322

322

-

322

Other

-

-

604

(7)

597

-

597

Total comprehensive income for the period

-

631

604

1,621

2,856

41

2,897

Equity settled share schemes

36

-

-

338

374

-

374

Issue and exchange of other equity instruments

-

1,142

-

-

1,142

-

1,142

Other equity instruments coupons paid

-

(631)

-

-

(631)

-

(631)

Vesting of shares under employee share schemes

-

-

(15)

(339)

(354)

-

(354)

Dividends paid

-

-

-

-

-

(40)

(40)

Other movements

-

(1)

-

1

-

9

9

Balance as at 30 September 2020

4,630

12,012

5,349

45,825

67,816

1,241

69,057

 

 

 

 

 

 

 

 

Three months ended 30.09.20

 

 

 

 

 

 

 

Balance as at 1 July 2020

4,620

10,871

6,996

45,817

68,304

1,237

69,541

Profit after tax

-

204

-

611

815

4

819

Retirement benefit remeasurements

-

-

-

(323)

(323)

-

(323)

Other

-

-

(1,646)

(1)

(1,647)

-

(1,647)

Total comprehensive income for the period

-

204

(1,646)

287

(1,155)

4

(1,151)

Equity settled share schemes

10

-

-

(265)

(255)

-

(255)

Issue and exchange of other equity instruments

-

1,142

-

-

1,142

-

1,142

Other equity instruments coupons paid

-

(204)

-

-

(204)

-

(204)

Vesting of shares under employee share schemes

-

-

(1)

(12)

(13)

-

(13)

Dividends paid

-

-

-

-

-

(3)

(3)

Other movements

-

(1)

-

(2)

(3)

3

-

Balance as at 30 September 2020

4,630

12,012

5,349

45,825

67,816

1,241

69,057

 

 

As at

As at

 

30.09.20

31.12.19

Other reserves

£m

£m

Currency translation reserve

3,848

3,344

Fair value through other comprehensive income reserve

(392)

(187)

Cash flow hedging reserve

1,745

1,002

Own credit reserve

(811)

(373)

Other reserves and treasury shares

959

974

Total

5,349

4,760

 

Appendix: Non-IFRS Performance Measures

 

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

 

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 

Non-IFRS performance measures glossary

 

Measure

Definition

Loan: deposit ratio

Loans and advances at amortised cost divided by deposits at amortised cost.

Period end allocated tangible equity

Allocated tangible equity is calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses.

Average tangible shareholders' equity

Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.

Average allocated tangible equity

Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.

Return on average tangible shareholders' equity

Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on page 41.

Return on average allocated tangible equity

Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on page 41.

Cost: income ratio

Total operating expenses divided by total income.

Loan loss rate

Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 23.

Net interest margin

Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 22.

Tangible net asset value per share

Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 49.

Performance measures excluding litigation and conduct

Calculated by excluding litigation and conduct charges from performance measures. The components of the calculations have been included on pages 42 to 49.

Pre-provision profits

Calculated by excluding credit impairment charges from profit before tax. The components of the calculation have been included on pages 42 to 44.

Pre-provision profits excluding litigation and conduct

Calculated by excluding credit impairment charges, and litigation and conduct charges from profit before tax. The components of the calculation have been included on pages 42 to 44.

 

Returns

 

Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.

 

 

Profit/(loss) attributable to ordinary equity holders of the parent

 

Average tangible equity

 

Return on average tangible equity

Nine months ended 30.09.20

£m

 

£bn

 

%

Barclays UK

165

 

10.2

 

2.2

Corporate and Investment Bank

2,141

 

27.2

 

10.5

Consumer, Cards and Payments

(362)

 

4.6

 

(10.6)

Barclays International

1,779

 

31.8

 

7.5

Head Office

(638)

 

6.5

 

n/m

Barclays Group

1,306

 

48.5

 

3.6

 

 

 

 

 

 

Nine months ended 30.09.19

 

 

 

 

 

Barclays UK

(157)

 

10.4

 

(2.0)

Corporate and Investment Bank

1,787

 

25.9

 

9.2

Consumer, Cards and Payments

632

 

5.3

 

15.8

Barclays International

2,419

 

31.2

 

10.3

Head Office

(482)

 

5.0

 

n/m

Barclays Group

1,780

 

46.6

 

5.1

 

Performance measures excluding litigation and conduct

 

 

 

 

 

 

 

 

Nine months ended 30.09.20

 

Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Cost: income ratio

£m

£m

£m

£m

£m

£m

Total operating expenses

(3,172)

(5,092)

(1,579)

(6,671)

(217)

(10,060)

Impact of litigation and conduct

36

6

33

39

31

106

Operating expenses

(3,136)

(5,086)

(1,546)

(6,632)

(186)

(9,954)

 

 

 

 

 

 

 

Total income

4,721

9,838

2,597

12,435

(331)

16,825

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

66%

52%

60%

53%

n/m

59%

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

Profit/(loss) before tax

264

3,243

(449)

2,794

(639)

2,419

Impact of litigation and conduct

36

6

33

39

31

106

Profit/(loss) before tax excluding litigation and conduct

300

3,249

(416)

2,833

(608)

2,525

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

Attributable profit/(loss)

165

2,141

(362)

1,779

(638)

1,306

Post-tax impact of litigation and conduct

25

4

25

29

18

72

Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct

190

2,145

(337)

1,808

(620)

1,378

 

 

 

 

 

 

 

Return on average tangible shareholders' equity

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

13.7

27.2

5.2

32.4

10.5

56.6

Average goodwill and intangibles

(3.5)

-

(0.6)

(0.6)

(4.0)

(8.1)

Average tangible shareholders' equity

10.2

27.2

4.6

31.8

6.5

48.5

 

 

 

 

 

 

 

Return on average tangible shareholders' equity excluding litigation and conduct

2.5%

10.5%

(9.9%)

7.6%

n/m

3.8%

 

 

 

 

 

 

 

Basic earnings per ordinary share

 

 

 

 

 

 

Basic weighted average number of shares (m)

 

 

 

 

 

17,298

 

 

 

 

 

 

 

Basic earnings per ordinary share excluding litigation and conduct

 

 

 

 

 

8.0p

 

 

 

 

 

 

 

Pre-provision profits

 

 

 

 

 

 

 

Profit before tax excluding credit impairment charges and litigation and conduct

 

 

 

 

 

£m

Profit before tax

 

 

 

 

 

2,419

Impact of credit impairment charges

 

 

 

 

 

4,346

Profit before tax excluding credit impairment charges

 

 

 

 

 

6,765

Impact of litigation and conduct

 

 

 

 

 

106

Profit before tax excluding credit impairment charges and litigation and conduct

 

 

 

 

 

6,871

 

 

Nine months ended 30.09.19

 

Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Cost: income ratio

£m

£m

£m

£m

£m

£m

Total operating expenses

(4,497)

(5,221)

(1,732)

(6,953)

(283)

(11,733)

Impact of litigation and conduct

1,524

30

-

30

128

1,682

Operating expenses

(2,973)

(5,191)

(1,732)

(6,923)

(155)

(10,051)

 

 

 

 

 

 

 

Total income

5,394

7,917

3,306

11,223

(286)

16,331

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

55%

66%

52%

62%

n/m

62%

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

Profit/(loss) before tax

375

2,596

882

3,478

(593)

3,260

Impact of litigation and conduct

1,524

30

-

30

128

1,682

Profit/(loss) before tax excluding litigation and conduct

1,899

2,626

882

3,508

(465)

4,942

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

Attributable (loss)/profit

(157)

1,787

632

2,419

(482)

1,780

Post-tax impact of litigation and conduct

1,489

26

-

26

96

1,611

Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct

1,332

1,813

632

2,445

(386)

3,391

 

 

 

 

 

 

 

Return on average tangible shareholders' equity

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

13.9

25.9

6.4

32.3

8.4

54.6

Average goodwill and intangibles

(3.5)

-

(1.1)

(1.1)

(3.4)

(8.0)

Average tangible shareholders' equity

10.4

25.9

5.3

31.2

5.0

46.6

 

 

 

 

 

 

 

Return on average tangible shareholders' equity excluding litigation and conduct

17.2%

9.3%

15.8%

10.4%

n/m

9.7%

 

 

 

 

 

 

 

Basic earnings per ordinary share

 

 

 

 

 

 

Basic weighted average number of shares (m)

 

 

 

 

 

17,192

 

 

 

 

 

 

 

Basic earnings per ordinary share excluding litigation and conduct

 

 

 

 

 

19.7p

 

 

 

 

 

 

 

Pre-provision profits

 

 

 

 

 

 

 

Profit before tax excluding credit impairment charges and litigation and conduct

 

 

 

 

 

£m

Profit before tax

 

 

 

 

 

3,260

Impact of credit impairment charges

 

 

 

 

 

1,389

Profit before tax excluding credit impairment charges

 

 

 

 

 

4,649

Impact of litigation and conduct

 

 

 

 

 

1,682

Profit before tax excluding credit impairment charges and litigation and conduct

 

 

 

 

 

6,331

 

Barclays Group

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Cost: income ratio

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Total operating expenses

(3,467)

(3,330)

(3,263)

 

(3,701)

(4,861)

(3,554)

(3,318)

 

(4,093)

Impact of litigation and conduct

76

20

10

 

167

1,568

53

61

 

60

Operating expenses

(3,391)

(3,310)

(3,253)

 

(3,534)

(3,293)

(3,501)

(3,257)

 

(4,033)

 

 

 

 

 

 

 

 

 

 

 

Total income

5,204

5,338

6,283

 

5,301

5,541

5,538

5,252

 

5,073

 

 

 

 

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

65%

62%

52%

 

67%

59%

63%

62%

 

79%

 

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

 

 

 

 

Profit before tax

1,147

359

913

 

1,097

246

1,531

1,483

 

374

Impact of litigation and conduct

76

20

10

 

167

1,568

53

61

 

60

Profit before tax excluding litigation and conduct

1,223

379

923

 

1,264

1,814

1,584

1,544

 

434

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable profit/(loss)

611

90

605

 

681

(292)

1,034

1,038

 

(14)

Post-tax impact of litigation and conduct

57

16

(1)

 

122

1,525

40

46

 

62

Profit attributable to ordinary equity holders of the parent excluding litigation and conduct

668

106

604

 

803

1,233

1,074

1,084

 

48

 

 

 

 

 

 

 

 

 

 

 

Return on average tangible shareholders' equity

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Average shareholders' equity

56.4

58.4

55.2

 

54.5

56.4

54.0

53.2

 

52.2

Average goodwill and intangibles

(8.1)

(8.2)

(8.2)

 

(8.1)

(8.0)

(7.8)

(8.0)

 

(7.9)

Average tangible shareholders' equity

48.3

50.2

47.0

 

46.4

48.4

46.2

45.2

 

44.3

 

 

 

 

 

 

 

 

 

 

 

Return on average tangible shareholders' equity excluding litigation and conduct

5.5%

0.8%

5.1%

 

6.9%

10.2%

9.3%

9.6%

 

0.4%

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per ordinary share

 

 

 

 

 

 

 

 

 

 

Basic weighted average number of shares (m)

17,298

17,294

17,278

 

17,200

17,192

17,178

17,111

 

17,075

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per ordinary share excluding litigation and conduct

3.9p

0.6p

3.5p

 

4.7p

7.2p

6.3p

6.3p

 

0.3p

 

 

 

 

 

 

 

 

 

 

 

Pre-provision profits

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit before tax excluding credit impairment charges and litigation and conduct

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Profit before tax

1,147

359

913

 

1,097

246

1,531

1,483

 

374

Impact of credit impairment charges

608

1,623

2,115

 

523

461

480

448

 

643

Profit before tax excluding credit impairment charges

1,755

1,982

3,028

 

1,620

707

2,011

1,931

 

1,017

Impact of litigation and conduct

76

20

10

 

167

1,568

53

61

 

60

Profit before tax excluding credit impairment charges and litigation and conduct

1,831

2,002

3,038

 

1,787

2,275

2,064

1,992

 

1,077

 

Barclays UK

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Cost: income ratio

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Total operating expenses

(1,120)

(1,024)

(1,028)

 

(1,122)

(2,432)

(1,063)

(1,002)

 

(1,175)

Impact of litigation and conduct

25

6

5

 

58

1,480

41

3

 

15

Operating expenses

(1,095)

(1,018)

(1,023)

 

(1,064)

(952)

(1,022)

(999)

 

(1,160)

 

 

 

 

 

 

 

 

 

 

 

Total income

1,550

1,467

1,704

 

1,959

1,846

1,771

1,777

 

1,863

 

 

 

 

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

71%

69%

60%

 

54%

52%

58%

56%

 

62%

 

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

 

 

 

 

Profit/(loss) before tax

196

(127)

195

 

647

(687)

477

585

 

390

Impact of litigation and conduct

25

6

5

 

58

1,480

41

3

 

15

Profit/(loss) before tax excluding litigation and conduct

221

(121)

200

 

705

793

518

588

 

405

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable profit/(loss)

113

(123)

175

 

438

(907)

328

422

 

241

Post-tax impact of litigation and conduct

17

5

3

 

43

1,457

30

2

 

12

Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct

130

(118)

178

 

481

550

358

424

 

253

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Average allocated equity

13.7

13.9

13.7

 

13.8

13.9

13.8

13.9

 

13.6

Average goodwill and intangibles

(3.6)

(3.6)

(3.6)

 

(3.5)

(3.5)

(3.5)

(3.5)

 

(3.5)

Average allocated tangible equity

10.1

10.3

10.1

 

10.3

10.4

10.3

10.4

 

10.1

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity excluding litigation and conduct

5.2%

(4.6%)

7.0%

 

18.7%

21.2%

13.9%

16.4%

 

10.1%

 

Barclays International

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Cost: income ratio

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Total operating expenses

(2,255)

(2,197)

(2,219)

 

(2,500)

(2,282)

(2,446)

(2,225)

 

(2,684)

Impact of litigation and conduct

28

11

-

 

86

-

11

19

 

33

Operating expenses

(2,227)

(2,186)

(2,219)

 

(2,414)

(2,282)

(2,435)

(2,206)

 

(2,651)

 

 

 

 

 

 

 

 

 

 

 

Total income

3,781

4,010

4,644

 

3,452

3,750

3,903

3,570

 

3,221

 

 

 

 

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

59%

55%

48%

 

70%

61%

62%

62%

 

82%

 

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

 

 

 

 

Profit before tax

1,165

807

822

 

640

1,137

1,223

1,118

 

215

Impact of litigation and conduct

28

11

-

 

86

-

11

19

 

33

Profit before tax excluding litigation and conduct

1,193

818

822

 

726

1,137

1,234

1,137

 

248

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable profit/(loss)

782

468

529

 

397

799

832

788

 

(21)

Post-tax impact of litigation and conduct

21

8

-

 

64

2

8

16

 

34

Profit attributable to ordinary equity holders of the parent excluding litigation and conduct

803

476

529

 

461

801

840

804

 

13

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Average allocated equity

31.2

34.2

31.9

 

31.9

33.3

32.1

31.6

 

32.4

Average goodwill and intangibles

(0.6)

(0.7)

(0.7)

 

(1.0)

(1.1)

(1.0)

(1.1)

 

(1.1)

Average allocated tangible equity

30.6

33.5

31.2

 

30.9

32.2

31.1

30.5

 

31.3

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity excluding litigation and conduct

10.5%

5.7%

6.8%

 

6.0%

10.0%

10.8%

10.6%

 

0.2%

 

Corporate and Investment Bank

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Cost: income ratio

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Total operating expenses

(1,719)

(1,683)

(1,690)

 

(1,926)

(1,716)

(1,867)

(1,638)

 

(2,046)

Impact of litigation and conduct

3

3

-

 

79

4

7

19

 

23

Operating expenses

(1,716)

(1,680)

(1,690)

 

(1,847)

(1,712)

(1,860)

(1,619)

 

(2,023)

 

 

 

 

 

 

 

 

 

 

 

Total income

2,905

3,316

3,617

 

2,314

2,617

2,795

2,505

 

2,151

 

 

 

 

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

59%

51%

47%

 

80%

65%

67%

65%

 

94%

 

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

 

 

 

 

Profit before tax

1,000

1,040

1,203

 

359

882

887

827

 

85

Impact of litigation and conduct

3

3

-

 

79

4

7

19

 

23

Profit before tax excluding litigation and conduct

1,003

1,043

1,203

 

438

886

894

846

 

108

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable profit/(loss)

627

694

820

 

193

609

596

582

 

(84)

Post-tax impact of litigation and conduct

2

2

-

 

58

5

5

16

 

27

Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct

629

696

820

 

251

614

601

598

 

(57)

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Average allocated equity

26.4

29.1

26.2

 

25.9

26.9

25.8

25.2

 

26.0

Average goodwill and intangibles

-

(0.1)

-

 

(0.1)

-

-

(0.1)

 

-

Average allocated tangible equity

26.4

29.0

26.2

 

25.8

26.9

25.8

25.1

 

26.0

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity excluding litigation and conduct

9.5%

9.6%

12.5%

 

3.9%

9.2%

9.3%

9.5%

 

(0.9%)

 

Consumer, Cards and Payments

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Cost: income ratio

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Total operating expenses

(536)

(514)

(529)

 

(574)

(566)

(579)

(587)

 

(638)

Impact of litigation and conduct

25

8

-

 

7

(4)

4

-

 

10

Operating expenses

(511)

(506)

(529)

 

(567)

(570)

(575)

(587)

 

(628)

 

 

 

 

 

 

 

 

 

 

 

Total income

876

694

1,027

 

1,138

1,133

1,108

1,065

 

1,070

 

 

 

 

 

 

 

 

 

 

 

Cost: income ratio excluding litigation and conduct

58%

73%

52%

 

50%

50%

52%

55%

 

59%

 

 

 

 

 

 

 

 

 

 

 

Profit before tax

 

 

 

 

 

 

 

 

 

 

Profit/(loss) before tax

165

(233)

(381)

 

281

255

336

291

 

130

Impact of litigation and conduct

25

8

-

 

7

(4)

4

-

 

10

Profit/(loss) before tax excluding litigation and conduct

190

(225)

(381)

 

288

251

340

291

 

140

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable profit/(loss)

155

(226)

(291)

 

204

190

236

206

 

63

Post-tax impact of litigation and conduct

19

6

-

 

6

(3)

3

-

 

7

Profit/(loss) attributable to ordinary equity holders of the parent excluding litigation and conduct

174

(220)

(291)

 

210

187

239

206

 

70

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity

£bn

£bn

£bn

 

£bn

£bn

£bn

£bn

 

£bn

Average allocated equity

4.8

5.1

5.7

 

6.0

6.4

6.3

6.4

 

6.4

Average goodwill and intangibles

(0.6)

(0.6)

(0.7)

 

(0.9)

(1.1)

(1.0)

(1.0)

 

(1.1)

Average allocated tangible equity

4.2

4.5

5.0

 

5.1

5.3

5.3

5.4

 

5.3

 

 

 

 

 

 

 

 

 

 

 

Return on average allocated tangible equity excluding litigation and conduct

16.5%

(19.6%)

(23.5%)

 

16.3%

14.0%

18.0%

15.4%

 

5.4%

 

Head Office

 

 

 

 

 

 

 

 

 

 

 

Q320

Q220

Q120

 

Q419

Q319

Q219

Q119

 

Q418

Profit before tax

£m

£m

£m

 

£m

£m

£m

£m

 

£m

Loss before tax

(214)

(321)

(104)

 

(190)

(204)

(169)

(220)

 

(231)

Impact of litigation and conduct

23

3

5

 

23

88

1

39

 

12

Loss before tax excluding litigation and conduct

(191)

(318)

(99)

 

(167)

(116)

(168)

(181)

 

(219)

 

 

 

 

 

 

 

 

 

 

 

Profit attributable to ordinary equity holders of the parent

 

 

 

 

 

 

 

 

 

 

Attributable loss

(284)

(255)

(99)

 

(154)

(184)

(126)

(172)

 

(234)

Post-tax impact of litigation and conduct

19

3

(4)

 

15

66

2

28

 

16

Attributable loss excluding litigation and conduct

(265)

(252)

(103)

 

(139)

(118)

(124)

(144)

 

(218)

 

Tangible net asset value per share

As at

As at

As at

 

30.09.20

31.12.19

30.09.19

 

£m

£m

£m

Total equity excluding non-controlling interests

67,816

64,429

66,197

Other equity instruments

(12,012)

(10,871)

(10,860)

Goodwill and intangibles

(8,163)

(8,119)

(8,068)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

47,641

45,439

47,269

 

 

 

 

 

m

m

m

Shares in issue

17,353

17,322

17,269

 

 

 

 

 

p

p

p

Tangible net asset value per share

 275

 262

 274

 

Shareholder Information

 

 

 

 

 

 

 

 

Results timetable1

 

 

Date

 

 

 

2020 Full Year Results and Annual Report

 

 

25 February 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% Change3

Exchange rates2

30.09.20

30.06.20

30.09.19

 

30.06.20

30.09.19

Period end - USD/GBP

1.29

1.24

1.23

 

4%

5%

YTD average - USD/GBP

1.27

1.26

1.27

 

1%

-

3 month average - USD/GBP

1.29

1.24

1.23

 

4%

5%

Period end - EUR/GBP

1.10

1.10

1.13

 

-

(3%)

YTD average - EUR/GBP

1.13

1.14

1.13

 

(1%)

-

3 month average - EUR/GBP

1.11

1.13

1.11

 

(2%)

-

 

 

 

 

 

 

 

Share price data

 

 

 

 

 

 

Barclays PLC (p)

97.61

114.42

150.40

 

 

 

Barclays PLC number of shares (m)

17,353

17,345

17,269

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For further information please contact

 

 

 

 

 

 

 

 

 

 

 

 

 

Investor relations

Media relations

Chris Manners +44 (0) 20 7773 2136

Tom Hoskin +44 (0) 20 7116 4755

 

 

 

 

 

 

 

 

 

 

 

 

 

 

More information on Barclays can be found on our website: home.barclays.

 

 

 

 

 

 

 

 

 

 

 

 

 

Registered office

 

 

 

 

 

 

1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.

 

 

 

 

 

 

 

 

Registrar

 

 

 

 

 

 

Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.

 

Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.

 

 

 

 

 

 

 

 

American Depositary Receipts (ADRs)

 

 

 

 

 

 

J.P.Morgan Chase Bank, N.A

StockTransfer@equiniti.com

Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada) or +1 866 700 1652 (for the hearing

impaired).

J.P.Morgan Chase Bank N.A., Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA.

 

 

 

 

 

 

 

Delivery of ADR certificates and overnight mail

 

 

 

 

 

 

J.P.Morgan Chase Bank N.A., Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA.

 

1

Note that these dates are provisional and subject to change.

2

The average rates shown above are derived from daily spot rates during the year.

3

The change is the impact to GBP reported information.

4

Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

 

Notes

 

The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the nine months ended 30 September 2020 to the corresponding nine months of 2019 and balance sheet analysis as at 30 September 2020 with comparatives relating to 31 December 2019 and 30 September 2019. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

 

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

 

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/investor-relations/reports-and-events/latest-financial-results. 

 

The information in this announcement, which was approved by the Board of Directors on 22 October 2020, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2019, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

 

These results will be furnished as a Form 6-K to the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.

 

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 

Non-IFRS performance measures

 

Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 40 to 49 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 

Forward-looking statements

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, payment of dividends (including dividend payout ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking statements speak only as at the date on which they are made and such statements may be affected by changes in legislation, the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the exit by the UK from the European Union (EU) (including the outcome of negotiations concerning the UK's future trading and security relationship with the EU) and the disruption that may subsequently result in the UK and globally; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group's control. As a result, the Group's actual financial position, future results, dividend payments, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in our filings with the SEC (including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2019 and our 2020 Interim Results Announcement for the six months ended 30 June 2020 filed on Form 6-K), which are available on the SEC's website at www.sec.gov.

 

Subject to our obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTUURWRROURUAA
Date   Source Headline
23rd Apr 20243:26 pmRNSForm 8.3 - WINCANTON PLC
23rd Apr 20243:26 pmRNSForm 8.3 - VIRGIN MONEY UK PLC
23rd Apr 20243:26 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20243:26 pmRNSForm 8.3 - UK COMMERCIAL PROPERTY REIT LTD
23rd Apr 20243:26 pmRNSForm 8.3 - QUANEX BUILDING PRODUCTS CORP
23rd Apr 20243:26 pmRNSForm 8.3 - TRITAX BIG BOX REIT PLC
23rd Apr 20243:25 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
23rd Apr 20243:25 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
23rd Apr 20243:25 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
23rd Apr 20243:25 pmRNSForm 8.3 - MATTIOLI WOODS PLC
23rd Apr 20243:24 pmRNSForm 8.3 -LOK'NSTORE GROUP PLC
23rd Apr 20243:24 pmRNSForm 8.3 - KIN & CARTA PLC
23rd Apr 20243:24 pmRNSForm 8.3 - DS SMITH PLC
23rd Apr 202411:37 amRNS38.5(b)- IRISH RESIDENTIAL PROPERTIES REIT PLC
23rd Apr 202411:35 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
23rd Apr 202411:34 amRNSForm8.5(EPT/NON-RI)INTERNATIONAL DISTRIBUT SERVI
23rd Apr 202411:34 amRNSForm 8.5 (EPT/NON-RI)GCP ASSET BACKED INCOME FUND
23rd Apr 202411:33 amRNSForm 8.5 (EPT/NON-RI)BARRATT DEVELOPMENTS PLC
23rd Apr 202411:33 amRNSForm8.5(EPT/NON-RI)BALANCED COMMERCIAL PROPE TRUS
23rd Apr 20247:30 amRNSTransaction in Own Shares
22nd Apr 20242:29 pmRNSForm 8.3 - WINCANTON PLC
22nd Apr 20242:29 pmRNSForm 8.3 - UK COMMERCIAL PROPERTY REIT LTD
22nd Apr 20242:29 pmRNSForm 8.3 -VIRGIN MONEY UK PLC
22nd Apr 20242:28 pmRNSForm 8.3 -TRITAX BIG BOX REIT PLC
22nd Apr 20242:28 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
22nd Apr 20242:28 pmRNSForm 8.3 - MONDI PLC
22nd Apr 20242:27 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
22nd Apr 20242:26 pmRNSForm 8.3 -MATTIOLI WOODS PLC
22nd Apr 20242:25 pmRNSForm 8.3 - LOK'NSTORE GROUP PLC
22nd Apr 20242:25 pmRNSForm 8.3 - KIN & CARTA PLC
22nd Apr 20242:25 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
22nd Apr 20242:24 pmRNSForm 8.3 - HIPGNOSIS SONGS FUND LTD/THE FUND
22nd Apr 20242:24 pmRNSForm 8.3 -DS SMITH PLC
22nd Apr 202412:03 pmRNS38.5(b) Report - IRISH RESIDENTIAL PROPERTIE REIT
22nd Apr 202411:49 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
22nd Apr 202411:49 amRNSForm 8.5 (EPT/NON-RI)GCP ASSET BACKED INCOME FUND
22nd Apr 202411:48 amRNSForm 8.5 (EPT/NON-RI)BARRATT DEVELOPMENTS PLC
22nd Apr 202411:48 amRNSForm8.5(EPT/NON-RI)INTERNATIONAL DISTRIBUTION SERV
22nd Apr 202411:48 amRNSForm 8.5 (EPT/NON-RI)BALANCED COMMERCIAL PROPE TRU
22nd Apr 20247:30 amRNSTransaction in Own Shares
19th Apr 20242:55 pmRNSForm 8.3 - VIRGIN MONEY UK PLC
19th Apr 20242:54 pmRNSForm 8.3 - WINCANTON PLC
19th Apr 20242:54 pmRNSForm 8.3 -UK COMMERCIAL PROPERTY REIT LTD
19th Apr 20242:54 pmRNSForm 8.3 - TRITAX BIG BOX REIT PLC
19th Apr 20242:54 pmRNSForm 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
19th Apr 20242:54 pmRNSForm 8.3 - INTERNATIONAL PAPER CO
19th Apr 20242:54 pmRNSForm 8.3 - SPIRENT COMMUNICATIONS PLC
19th Apr 20242:53 pmRNSForm 8.3 - MONDI PLC
19th Apr 20242:53 pmRNSForm 8.3 - KIN & CARTA PLC
19th Apr 20242:51 pmRNSForm 8.3 - HIPGNOSIS SONGS FUND LTD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.